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SUMMARY 
 
Alcohol-induced psychotic disorder (also known as alcohol hallucinosis) is a  
complication of alcohol abuse that requires clinical differentiation from alcohol 
withdrawal delirium and schizophrenia.  Although extensively described, few 
studies utilized standardized research instruments and brain-imaging has thus 
far been limited to case reports.  The aim of this study was to prospectively 
compare four population groups (ie. patients with alcohol-induced psychotic 
disorder, schizophrenia, uncomplicated alcohol dependence and a healthy 
volunteer group) according to demographic, psychopathological and brain-
imaging variables utilizing (i) rating scales and (ii) single photon emission 
computed tomography (SPECT). The third component of the study was 
designed to investigate the (iii) effect of anti-psychotic treatment on the 
psychopathology and regional cerebral blood flow (rCBF) before and after six 
weeks of treatment with haloperidol.  Effort was made to ensure exclusion of 
comorbid medical disorders, including substance abuse. The study provides 
further supportive evidence that alcohol-induced psychotic disorder can be 
distinguished from schizophrenia. Statistically significant differences in rCBF 
were demonstrated between the alcohol-induced psychotic disorder and other 
groups.  Changes in frontal, temporal, parietal, occipital, thalamic and 
cerebellar rCBF showed statistically significant negative correlations with 
post-treatment improvement on psychopathological variables and imply 
dysfunction of these areas in alcohol-induced psychotic disorder.  The study 
was unable to distinguish between pharmacological effects and improvement 
acccomplished by abstinence from alcohol.  
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OPSOMMING 
 
Alkohol-geïnduseerde psigose (ook bekend as alkohol hallusinose) is ‘n 
komplikasie van alkoholmisbruik wat kliniese onderskeid van 
alkoholonttrekkings-delirium en skisofrenie benodig.  Alhoewel reeds 
omvattend beskryf, het min studies tot dusver gestandardiseerde navorsing 
instrumente gebruik en breinbeelding is beperk tot gevallestudies.  Die doel 
van die studie was om vier studiegroepe (nl. pasiënte met alkohol-
geïnduseerde psigose, skisofrenie, ongekompliseerde alkoholafhanklikheid en 
‘n gesonde vrywilliger groep) prospektiewelik volgens demografiese, 
psigopatologiese en breinbeelding veranderlikes te vergelyk deur van (i) 
meetskale en (ii) enkel foton emissie rekenaar tomografie (“SPECT”) gebruik 
te maak.  Die derde deel van die studie was ontwerp om die (iii) effek van   
anti-psigotiese behandeling op die psigopatologie en serebrale 
streekbloedvloei (“rCBF”) voor en na ses weke behandeling met haloperidol te 
ondersoek.  Voorsorg was gemaak om uitsluiting van gepaardgaande 
mediese toestande insluitende substansmisbruik te verseker.  Die studie 
verskaf verdere ondersteunende getuienis dat alkohol-geïnduseerde psigose 
van skisofrenie onderskei kan word. Statisties betekenisvolle verskille in 
serebrale streekbloedvloei tussen die alkohol-geïnduseerde psigose en ander 
groepe was aangetoon. Veranderings in frontale, temporale, pariëtale, 
oksipitale, talamiese en serebellêre streekbloedvloei het statisties 
betekenisvolle negatiewe korrelasies met na-behandeling verbetering in 
psigopatologiese veranderlikes getoon en impliseer disfunksie in hierdie 
gebiede.  Die studie was nie in staat om tussen farmakologiese effekte en 
beterskap op grond van onthouding van alkohol te onderskei nie.  
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1.  INTRODUCTION and LITERATURE REVIEW 
Alcohol-induced psychotic disorder is an uncommon but well-known 
psychiatric disorder. It however presents relatively frequently in the catchment 
area of Tygerberg Hospital in the Western Cape in South Africa.  
 
The term “psychosis” is defined as an “inability to distinguish reality from 
fantasy; impaired reality testing, with the creation of a new reality” (Sadock & 
Sadock, 2003).  It is mostly associated with delusions, hallucinations, thought 
process disorder and inappropriate behaviour. The most common disorders 
that present with psychotic features are schizophrenia, mood disorders (such 
as major depression with psychosis and both the manic and depressive 
phases of bipolar disorder), delusional disorders, psychotic disorders due to a 
general medical condition and substance-induced psychotic disorders.   
 
It is known that psychotic manifestations may occur in a number of syndromes 
associated with alcoholism (Greenberg & Lee, 2001).  In current terminology, 
Wernicke’s encephalopathy can be viewed as a confusional state or delirium 
accompanied by neurological signs, while Korsakoff’s psychosis is 
predominantly an amnestic (memory) disorder.   Both these syndromes are 
regarded as different facets of the same pathologic process due to thiamine 
deficiency usually associated with alcoholism. Psychotic features may also be 
a common occurrence in alcoholic dementia similar to other dementias. Other 
alcohol related syndromes that may be associated with psychotic features 
include alcoholic pellagra encephalopathy, hepatic encephalopathy, 
Marchiafava-Bignami disease and central pontine myelinosis. The psychotic 
 9
features occurring in these syndromes are however predominantly associated 
with comorbid neurological deficits or other medical impairment and usually 
do not present as a distinct psychotic syndrome only.   
 
1.1  Recognition of the Syndrome 
The association between alcohol use and psychosis was documented as 
early as 1847 by Marcel who described “madness as a result of drinking, 
madness of a drunkard, drunken madness” and called it “folie d’ivrogne”  
(Marcel, 1847). Although Marcel has been credited for differentiating the 
disorder from delirium tremens (Johansson, 1961), German psychiatrists  
(Wernicke, 1881; Korsakoff, 1887; Ziehen, 1894 and Kraepelin, 1913) also 
acknowledged that some patients with alcohol dependence presented with a 
distinct psychotic syndrome that differred from delirium tremens (alcohol 
withdrawal with delirium), Wernicke’s encephalopathy, Korsakoff’s psychosis 
and alcohol-induced dementia.   (Glass, 1989).  
 
Various discriptions about the nature of and outcome of a distinct psychotic 
syndrome associated with alcoholism followed.  Kraepelin (1913) described 
the disorder as follows:  
 
“ The picture of disease which has a certain resemblance to delirium tremens, 
in the fantastic delusions, the vividness of hallucinations, the remarkable 
combination of insane ideas with a sense of illness and the alcoholic origin.  It 
differs from delirium chiefly in its much longer duration, in the absence of any 
disturbance of the patients’s idea of his position, and in the predominance of 
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the hallucinations of hearing compared with the prevalence of hallucinations 
of sight in delirium tremens. The unrest, too, is generally less, and the tremors 
are not nearly so pronounced.  For these reasons it seems best to clearly 
distinguish this illness from delirium tremens, although the two are certainly 
nearly related........Its course may extend over several weeks or months. The 
outcome is generally complete recovery but there is no inconsiderable 
number of cases in which incurable states of weakness remain, usually with 
particular permanent hallucinations and delusions. “     (Glass, 1989).         
 
Bleuler (1916) termed the condition alcoholic hallucinosis and described the 
disorder in the following way:  
 
“Alcoholic insanity is in many respects the opposite to delirium tremens. It 
manifests itself chiefly in auditory hallucinations, which have a peculiar 
character: that is they discuss him in the third person; much more rarely they 
speak to him.  These voices threaten him also... Visions similar to those in 
delirium tremens may also appear intermingled with others. ...Delusions of 
persecution correspond to the hallucinations......At the same time patients 
remain orientated and.... they generally remain clear.  Attention appears to be 
normal......Memory in all cases is good,.... the behaviour is proper. The 
dominant affect is anxiety. The patients are relatively indifferent......suicide is 
not rare. Physical symptoms are insignificant. Alcoholic insanity usually 
breaks out very acutely.  Repeated attacks are not rare. As a rule the disease 
passes over into recovery.......It is a question whether the delusions and 
hallucinations can continue to exist in a chronic form.”     (Glass, 1989).               
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These early descriptions were based on individual case-studies and clinical 
experience.  Follow-up studies on groups of patients appeared in the literature 
from around the 1950’s.  These early descriptions as well as the studies that 
followed contain the core features of the syndrome which is currently known 
as: Alcohol-induced Psychotic Disorder (DSM IV, 1994) and Psychotic 
Disorder due to the use of Alcohol (ICD-10, 1993). (For the purpose of this 
discussion the term alcohol hallucinosis and alcohol-induced psychotic 
disorder would be used synonomously).  
 
1.2  Description of  the Syndrome  
Authors generally agreed that the disorder is especially characterized by 
acute onset of auditory hallucinations, but also by delusions in a clear 
consciousness  (Seitz 1951, Sokya 1988), in someone with a history of heavy 
drinking. The hallucinations are usually auditory in nature and typified by 
voices presenting unpleasant messages to the patient. The symptoms usually 
clear within a week, but sometimes tend to become chronic, especially in the 
presence of ongoing alcohol abuse (Glass 1989).  
 
The early follow-up studies on groups of patients with alcohol hallucinosis by 
Benedetti (1952), Burton-Bradley (1958) and Victor & Hope (1958) did not 
compare their patients with patients from other diagnostic groups.   
Conclusions were rather formulated on grounds of their clinical observations  
and follow-up over a variable length of time.  Since the 1960’s study reports 
by Johansson (1961), Scott (1967, 1969), Cutting (1978), Soyka (1988, 1990) 
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and Tsuang (1994) utilized a more systematic research approach, comparing 
the onset, clinical presentation and course in patients with alcohol hallucinosis 
with patients with delirium tremens, schizophrenia, chronic alcoholism, toxic 
confusion and alcoholic paranoia.        
 
Benedetti (1952) 
He followed up 113 patients with alcohol hallucinosis over long periods, on 
average approximately 10 years, but some up to 41 years.  All patients 
presented with acute onset.  He documented the course of the disorder and 
its possible relationship to body build, family history and premorbid 
personality. About 30% of patients had a relapsing course and relapse 
occurred more often in the patients who developed a chronic illness. 
Interesting to note is that a minority of patients continued to experience 
hallucinations in spite of abstinence  whilst others were resistant to relapse in 
spite of ongoing drinking.    
 
He demonstrated that his patients had a varied outcome.  Some patients 
(10%) had symptoms suggestive of a delirium in the acute phase. The 
majority of patients (80%) recovered within six months. Of those that 
remained chronic, approximately half developed schizophrenia while the other 
half developed a dementing illness associated with concomitant physical 
impairment.  (Glass, 1989) 
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Burton-Bradley (1958)  
Burton-Bradley reported on 41 patients and agreed that the majority did not 
resemble schizophrenia.  Hallucinations cleared within one month in 35 of 
these patients. The appropriateness of behaviour to the hallucinatory content, 
absence of thought disorder and complete and rapid recovery distinguished 
these patients from the features usually associated with schizophrenia.  It was 
noted that acute alcoholic hallucinosis could at the most be considered a very 
special subgroup of schizophrenia. Though the study supported the non-
schizophrenic nature of acute alcoholic hallucinosis, the evidence was 
inconclusive. (Glass, 1989) 
 
Victor & Hope (1958) 
These authors followed up 70 patients over a period of approximately 5 years.  
Their findings supported the previous reports that alcohol hallucinosis was an 
acute illness with a benign course when compared to schizophrenia.  The 
majority of their patients reflected no relationship to schizophrenia.  They did 
however report a chronic form of the illness which occurred in 8 out of 76 
cases.  In four of these cases the illness could not be distinguished from 
schizophrenia.  In three patients diagnosed with schizophrenia transient 
episodes of auditory hallucinations were associated with excessive drinking.   
Their findings also suggested that repeated episodes of hallucinosis may 
contribute to the development of chronic forms of the illness.     
 
They dismissed the idea that alcohol triggered latent schizophrenia as a 
possible release mechanism for the development of schizophrenia.  They 
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argued that they were unable to detect a difference in terms of age, sex, 
personality, alcoholic habits and mode of onset between the alcoholic patients 
who developed a schizophrenia-like illness and those who did not.  (Glass, 
1989). 
 
Johansson (1961) 
Johansson reported on 38 alcoholic patients with hallucinosis and paranoid 
features and compared them to a group of patients with delirium tremens.   
She found that patients with delirium tremens were older and had longer 
alcohol histories compared to those in the hallucinosis group.  Patients with 
delirium tremens seemed to be slightly better equiped socially and 
intellectually, whilst the hallucinosis group had significantly more often head 
injuries.  Johansson reported that the onset of illness in the hallucinosis group 
was significantly higher than the average age of onset of a previous group of 
patients with schizophrenia.  She also confirmed the acute onset, brief 
duration and comparatively good prognosis of patients with alcohol 
hallucinosis.   (Glass, 1989). 
 
Scott (1969) 
Only six of the 33 patients in this study, in which some patients were followed 
up for up to 17 years, represented the acute illness and good outcome that 
were described by other authors. These six patients had hallucinations that 
lasted 8 weeks or less.  Seventeen patients were diagnosed as as having 
other diagnoses such as manic-depressive illness, schizophrenic illness, 
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personality disorder and drug addiction during the course of the follow-up 
period.  This obviously makes any results difficult to interpret. ( Glass, 1989). 
 
Cutting (1978) 
This retrospective study studied the nature of alcoholic psychosis through 
case notes of 114 patients diagnosed as alcoholic psychosis over a period of 
27 years.  Patients with Korsakoff’s syndrome and alcoholic dementia were 
excluded from this group.   Patients were divided into 6 diagnostic categories 
namely alcoholic hallucinosis (40%), delirium tremens (21%), alcoholic 
psychosis unspecified (18%), toxic confusion (7%), alcoholic paranoia (6%) 
and a mixed group “alcoholic hallucinosis? schizophrenia”.   
 
Further episodes of illness occurred in 26 of the 46 patients diagnosed with 
alcohol hallucinosis.  Nine of the 46 patients were lost to follow-up.  Of the 
remaining patients, 10 patients (27%) remained well and one remained 
unchanged.  Only 7 patients (19%) presented with a further episode of 
alcoholic hallucinosis, 8 patients (22%) were diagnosed with affective illness, 
4 patients (11%) with schizophrenia and 2 patients (5%) committed suicide.  
Two patients (5%) returned with delirium tremens,  two patients (5%) with a 
paranoid psychosis and in one patient the nature of the alcoholic psychosis 
was unknown.  Given these figures, it is evident that the diagnosis of alcoholic 
hallucinosis remained unchanged in at least 17 (46%) of the patients originally 
diagnosed with alcoholic hallucinosis.  The significance of this study however  
therefore lie in the varied outcome that was demonstrated.              
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Soyka (1988, 1990) 
These retrospective studies compared psychopathology in patients diagnosed 
with alcohol hallucinosis to those with delrium tremens (1988) and paranoid 
schizophrenia  (1990) respectively. The first study (1988) examined the case 
histories of 154 patients with alcoholic psychosis: 103 patients with alcohol 
withdrawal delirium and 51 patients with alcohol hallucinosis.  All the patients 
with clouding of consciousness and disorientation were diagnosed as alcohol 
withdrawal delirium, while those with a clear sensorium were diagnosed as 
alcohol hallucinosis. No significant differences between the two groups were 
reported with regard to mean age or sex ratio.  When comparing 
psychopathology,  the alcohol hallucinosis group scored significantly higher 
than the alcohol withdrawal delirium group on the following: delusions of 
reference (33.3% vs 12.6%, p<0.01), delusions of persecution (60.8% vs 
36.8%, p<0.01), verbal hallucinations (84.3% vs 38.8%, p<0.001), and anxiety 
(80.3% vs 60.2%, p<0.05).  The alcohol withdrawal delirium group scored 
significantly higher than the alcohol hallucinosis group on visual hallucinations 
(74.7% vs 29.4%, p<0.001).   Delusions occurred in both groups, but were 
generally more common in the alcohol hallucinosis group.   
 
Depressed mood (33.9% vs 39.2%) and suicidal tendencies (7.7% vs 17.6%) 
were common to both alcohol withdrawal delirium and hallucinosis groups 
respectively, and did not show statistical difference.  Only patients with 
alcohol hallucinosis tried to commit suicide though.   
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The authors concluded that the two conditions have a distinct association with 
chronic alcoholism, but that it differs with regard to a number of   
psychopathological aspects as well as to the onset and course. Alcohol 
withdrawal delirium usually starts after 2-4 days of cessation of drinking.  The 
onset and course of alcohol hallucinosis are difficult to predict. Clinical 
differentiation is important because the management of the two disorders 
differ.      
 
The second retrospective study (1990) included a comparison of the 
psychopathology, family histories and individual psychiatric histories of a  
group of 53 patients with alcohol hallucinosis with an age- and sex-matched 
control group of 53 patients with paranoid schizophrenia.  Patients were 
diagnosed according to ICD-9 and DSM-III.  Patients with schizophrenia and a 
history of alcohol or drug abuse and patients with “organic mental disorders” 
were excluded from the study.        
 
Although formal thought disorders were observed in both groups of patients,  
the reported frequencies were generally low (< 35%).  The only exception was 
one item of thought disorder namely “incoherence” which occurred 
significantly more often in the schizophrenia than in the alcohol hallucinosis 
group (43% vs 17%; p<0.01).    
 
No significant differences were observed with regard to disorders of affect 
such as anxiety (77%  vs 71%), depressed mood (47% vs 54%) and blunted 
affect (24% vs 28%) in the alcohol hallucinosis and schizophrenia groups 
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respectively. Affective rigidity (p<0.05), ambivalence (p<0.001), and 
suspiciousness (p< 0.001) were reported more often in patients with 
schizophrenia.          
 
With regard to disorders of perception, it is interesting to note that all the 
patients with alcohol hallucinosis experienced verbal (auditory) hallucinations 
(100% vs 83%;p<0.01) compared to patients with paranoid schizophrenia.   
Auditory hallucinations often occurred in the context of threatening or 
accusatory voices.  Hallucinations in other sensory modalities such as vision 
(43% in alcohol hallucinosis vs 34% in schizophrenia groups), did not 
significantly differ between the groups.  
 
Delusions generally occurred in both groups but delusions of persecution 
(88% vs 71%;p<0.05) and delusions of reference (77% vs 45%;p<0.01) were 
more commonly reported in the schizophrenia group.    
 
Disorders of ego were the most distinct psychopathological disturbance that 
differed between the groups. No ego disturbances were reported in 70% of 
alcohol  hallucinosis patients vs 13% in patients with schizophrenia (p<0.001).  
When comparing the schizophrenia group with the alcohol hallucinosis group,   
thought broadcasting (35% vs 13%;p<0.01), thought insertion (20% vs 
3%;p<0.01) and feelings of alien influence (64% vs 24%; p<0.001) all 
occurred significantly more in patients with schizophrenia.   
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The family histories of the patients with alcohol hallucinosis and paranoid 
schizophrenia indicated that first-degree relatives of patients with 
schizophrenia were more commonly diagnosed with schizophrenia compared 
to the first degree relatives of patients with alcohol hallucinosis (20% vs 2%; 
p<0.001).  Likewise the first-degree relatives of patients with alcohol 
hallucinosis were more likely to have an alcohol history compared to the first 
degree relatives of patients with schizophrenia (39% vs 2%; p<0.001).  
 
Patients with schizophrenia first developed psychotic symptoms earlier than 
patients with alcohol hallucinosis (mean age: 32.8 vs 37.4 years).  Patients 
with alcohol hallucinosis had a more favourable outcome to those with 
schizophrenia. On discharge, 85% of patients with alcohol hallucinosis and 
55% of patients with schizophrenia were reported to be symptom-free.   
 
In conclusion, it was clear that paranoid and hallucinatory symptoms are  
frequent occurrences in both alcohol hallucinosis and paranoid schizophrenia. 
The results however support the notion that the two disorders can be 
distinguished with regard to other psychopathological features such as 
disorders of ego,  family history, age of onset and prognosis.                
 
Tsuang (1994) 
This study was designed to evaluate the characteristics of male patients with 
a history of alcohol hallucinosis whose illness was independent of major 
psychiatric disorder or other drug use.  A group of patients with a history of 
alcohol hallucinosis (n=48) was compared with a group of alcoholic patients 
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(n=484) without a history of hallucinations. No significant differences on 
demographic data such as age, educational level, marital status or 
employment were found between the groups.  Patients with a history of 
alcohol hallucinosis were significantly younger at their age of first occurrence 
of major problems related to alcohol.  They also reported a higher average 
and greater maximum quantity of alcohol drinks per day.  Their lifetime drug 
consumption history indicated that patients with alcohol hallucinosis had 
higher rates of drug experimentation and higher mean number of drugs used.  
Interestingly, a higher percentage of men with alcoholic hallucinosis had 
histories of depression lasting more than 2 weeks.  First degree relatives with 
histories of schizophrenic disorders were similarly represented in both groups, 
supporting the view that alcohol hallucinosis is independent of a schizophrenic 
syndrome.               
 
1.3  Controversial Issues relating to the Diagnosis.         
It is interesting to note that not all authors agreed to the concept of a distinct 
syndrome caused by alcohol. Controversy about the nature of the disorder 
has characterized the literature and endured for many years (Glass, 1989). 
The controversy mainly revolves around etiological and phenomenological 
aspects concerning the disorder. These uncertainties include: whether 
hallucinations other than auditory are present, whether consciousness is 
always clear, whether orientation is completely intact, whether there are signs 
of cognitive impairment and what the natural course of the disorder entails.  
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Henderson & Gillespie (1936) suggested that similar hallucinoses could occur 
in the absence of alcoholism.  Schneider (1928) was of the opinion that 
patients who developed alcohol hallucinosis tended to be manic-depressive,  
while Suwaki et al (1976) also suggested the possible association with mood 
disorders such as depression with paranoid features.  May & Ebaugh (1953) 
considered it to be a schizophrenic reaction precipitated by alcohol and 
therefor a “waste-paper basket category”.  
 
Huber (1939)  suggested two forms of alcohol hallucinosis namely one with a 
delirium tremens component  and one with a schizophrenia component.  It 
was however postulated that alcohol hallucinosis is an independent syndrome 
that could indirectly precipitate a latent form of schizophrenia.     The studies 
of Benedetti (1952), Scott (1967, 1969) and Cutting (1978) (discussed earlier) 
also pointed towards a varied outcome.   
 
Most of the controversy can however be attributed to the nature of the 
disorder whose symptomatology overlaps with that of delirium tremens 
(alcohol withdrawal with delirium) and with schizophrenia. Alcohol induced 
psychotic disorder has to be distinguished from  alcohol withdrawal delirium 
(Sokya 1988, Gross 1968, Sobczyk 1983),  other psychotic disorders such as 
schizophrenia (Glass 1989, Soyka 1990),  psychoses associated with 
epilepsy  (Slater et al, 1963, Roberts et al , 1990, Nicolson et al 2007) and 
head injuries (David & Prince, 2005).   
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1.3.1 Association with Alcohol Withdrawal Delirium “Delirium Tremens”  
The classic alcohol withdrawal delirium (“delirium tremens”) can present 
similarly and many authors have assumed a close relationship between the 
two disorders. Various descriptions have been documented eg. “systematized 
pattern of delusions in a delirium of an alcoholic type” and  “alcoholic delirium 
of an auditory type”.   Kraepelin believed that delirium tremens and alcoholic 
hallucinosis were related features of the same process.  He however pointed 
out that the course of the disorder was shorter in delirium tremens and that 
the hallucinations were more likely visual than auditory.  He also 
acknowledged the possibility of a more chronic course in alcohol hallucinosis 
which ought to be differentiated from schizophrenia.  Bowman & Jellinek 
(1941), likewise, noted the longer duration of alcoholic hallucinosis.  They 
supported the observation that patients with alcoholic hallucinosis were 
usually orientated with intact attention and free of psychomotor agitation. They 
were also of the opinion that patients with alcohol hallucinosis had more 
introverted personalities and their family histories were more suggestive of 
psychiatric illness than those patients with delirium tremens.  
 
In investigating etiological factors, Scott (1967), found no differences in the 
marital, occupational and social status amongst 3 groups of patients 
diagnosed with alcoholic hallucinosis, chronic alcoholism without psychosis 
and delirium tremens.  Although he stated that classical alcohol hallucinosis 
does not include delirious features such as disorientation, he indicated that 
“there are some cases in which delirious features are present”.                 
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Gross et al (1968,1970,1972a,1972b) challenged the distinction between 
alcoholic hallucinosis with a clear sensorium and delirium tremens with visual 
hallucinations and clouding of consciousness.  They proposed a spectrum of 
acute hallucinatory states allowing for mild clouding of consciousness in 
alcoholic hallucinosis.        
   
Soyka et al (1988) addressed this issue extensively (as discussed in the 
previous section) and concluded that the two disorders can be distinguished 
clinically. The most important criteria of demarcation were clouding of 
consciousness and disorientation which were present in all patients with 
alcohol withdrawal delirium. Visual hallucinations were found significantly 
more in patients  with alcohol withdrawal with delirium as opposed to auditory 
hallucinations which were significantly more common in the patients with 
alcoholic hallucinosis.                   
 
1.3.2 Association with Schizophrenia 
The distinction from schizophrenia (especially paranoid schizophrenia) is 
also historically controversial, in view of the fact that alcohol hallucinosis may 
be difficult to clinically distinguish from (i) schizophrenia with secondary 
alcohol dependence (“self-medication hypothesis”). Other considerations are 
that alcohol hallucinosis is (ii) a latent form of schizophrenia precipitated by 
alcohol, (iii) a psychotic disorder  that arises as a direct toxic effect of alcohol 
or (iv) a coincidental occurrence of schizophrenia in someone with a history of 
chronic drinking.   
 24
The possibility that alcohol could act as an independent etiological agent in 
the development of a specific psychosis was initially dismissed by many 
authors. Bleuler was of the opinion that alcoholic hallucinosis could be a 
syndrome of schizophrenia induced by alcohol. Bleuler accepted that 
disorders of thought and language as well flattening of affect were central to 
the diagnosis of schizophrenia. The notion of alcoholic hallucinosis as a latent 
form of schizophrenia was prominently received in the literature in spite of the 
relative absence of these symptoms in alcohol hallucinosis. Davidson (1939) 
was of the opinion that alcoholism and the hallucinosis both reflected 
symptoms of an underlying schizophrenia.   
 
As mentioned earlier in this section, the studies by Burton-Bradley (1958) and  
Victor & Hope (1958) supported the non-schizophrenic nature of alcohol-
induced psychosis. Surawicz (1980) pointed out that: “Alcoholic hallucinosis 
differs from schizophrenia in several respects including age, family history, 
duration, premorbid personality, affect and the absence of formal thought 
disorder.”  The study by Soyka (1990) (see previous section) supported the 
existence of alcohol hallucinosis as a disorder independent of schizophrenia.      
 
Glass (1989) in her comprehensive review on the subject was struck by the 
lack of consistency in the diagnostic criteria for alcohol hallucinosis at that 
time.  The articles by Soyka et al (1988, 1990) were published before and 
after her review and thus probably both not available at the time of the review.     
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The distinction from alcohol withdrawal delirium and schizophrenia is clinically  
relevant, because the management and prognosis differ from that of alcohol 
induced psychotic disorder. Alcohol-induced psychotic disorder is an 
indication for anti-psychotic treatment. Hallucinations and delusions usually 
clear within a few days to weeks with anti-psychotic treatment. Alcohol free 
patients then usually do not require further neuroleptic treatment and the 
prognosis is usually good.    
 
Sometimes alcohol-induced psychotic disorder is incorrectly diagnosed as 
schizophrenia and these patients then receive unneccesary anti-psychotic 
treatment for indefinite periods (Soyka 1990).  Schizophrenic patients with co-
morbid alcohol abuse and/or dependence often contribute to diagnostic and 
therapeutic uncertainty. Clinical markers assisting in early distinguishing 
between the two disorders, would therefor also be beneficial in the 
introduction of appropriate management and avoiding of unneccesary 
treatment.  The similarites and differences between alcohol induced psychosis 
and schizophrenia is a rich topic for comparative research between the two 
disorders.  
 
One aspect that may assist in the quest to distinguish the pathogenesis and 
neurobiology of the two disorders is the presence of positive (present) and 
negative (absent or deficit) symptoms that have been described in 
schizophrenia (Strauss et al 1974).  Crow (1980) postulated that these 
positive symptoms represent a hyperdopaminergic state whilst the negative 
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symptoms reflect structural brain-deficit in schizophrenia.  Prodromal and 
residual symptoms seem to coincide with the negative syndrome in 
schizophrenia but appear to be relatively infrequent in alcohol-induced 
psychotic disorder.    The Positive and Negative Syndrome Scale (PANSS) 
(Kay et al 1987) was consequently developed and provides a valuable clinical 
and research instrument to explore the psychopathology of schizophrenia.  
Several  studies have assessed the factorial validity of the PANSS in 
schizophrenia (Emsley et al, 2003).  Not only did the negative and positive 
symptoms emerge as distinct components, but three addtional components 
have subsequently emerged. Current thinking favours a five factor structure 
for schizophrenia consisting of positive (p1,p3,p5,p6,g9,g12), negative 
(n1,n2,n3,n4,n6,g7,g13,g16), disorganized (p2,n5,n7,g5,g10,g11,g15), 
excitement (p4,p7,g8,g14), and depression/anxiety (g1,g2,g3,g4,g6), factors. 
(See table 4 and table 6).  Furthermore, the occurrence of positive and 
negative symptoms as described in schizophrenia has not been investigated 
in alcohol-induced psychotic disorder.  
 
1.4  Lack of  Standarized Research Methods: 
Another reason for the controversy lies with the lack of standardized research 
methods used to explore the nature of the disorder. Past studies have mainly 
dealt with descriptive aspects including the natural course and the possible 
contributing genetic factors concerning the development of the disorder 
(Benedetti 1952, Burton-Bradley 1958, Victor & Hope 1958, Johansson 1961, 
Scott et al 1967,  Cutting 1978 & Soyka, 1988, 1990).  
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It is evident (Glass 1989), that standardised interviews and rating scales 
including reliability data for the evaluation of personal history, alcohol history, 
premorbid personality, medical history and mental status examination were 
lacking during initial and subsequent assessments for most studies. Most 
information was collected from clinical notes.  It is readily understood that the 
descriptive case histories that appeared in the literature utilized different 
inclusion and exclusion criteria making comparison difficult. Biochemical and 
hematological investigations, urinary toxicological screening and 
psychological testing were documented in few studies. Brain imaging was 
probably not available for most investigators.  
 
There is therefore a need for standardized documentation of alcohol induced 
psychosis along with the use of tecnological instruments (eg. brain imaging) 
that have thus far not been systematically researched in this disorder. 
Currently, standardised psychiatric rating scales such as the Positive and 
Negative Syndrome Scale for Schizophrenia (PANSS) as well as 
technological measures such as Single Photon Emission Computed 
Tomography (SPECT) are available.  According to Soyka (1990),  research on 
biological aspects of brain function and morphology in alcohol induced 
psychosis could also contribute to develop a better understanding of the 
biological underpinnings of schizophrenia.       
 
1.5   Etiology of the Syndrome  
Increase in central dopaminergic activity, subsensitiviy of the dopamine 
receptor (Borg et al, 1986: Fadda et al, 1989; Soyka, 1993), serotonin 
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dysfunction (Soyka, 1993, 1997; Branchey et al, 1985), altered beta-carboline 
activity (Rommelspacher et al, 1991),  involvement of essential fatty acids 
(Glen et al, 1989) and possible damage to auditory and sensory pathways 
(Spitzer, 1981), have all been investigated as possible mechanisms for the 
development of hallucinations in patients with alcoholism.  Although a variety 
of different hypotheses have been suggested, none have thus far been able to 
explain the occurrence of psychotic symptoms in patients with alcoholism. 
(Soyka, 1995)    
 
Genetic studies have mainly contributed to distinguishing alcohol hallucinosis 
from schizophrenia. Brain-imaging remains a promising but relatively 
underutilized research technique available to unravel the pathogenesis of this 
disorder  These strategies will briefly be discussed below.       
 
1.5.1  Genetic Studies 
There is substantial evidence that genes play a role in the development of 
alcoholism.  It is also widely accepted that a single or a few genes are unlikely 
responsible for the vulnerability to alcoholism.  Family, twin and adoption 
studies have been utilized to explore the relationship between alcohol 
hallucinosis, alcoholism, delirium tremens and schizophrenia.  Four of the 
follow-up studies mentioned earlier, studied the famliy histories of patients 
with alcohol hallucinosis.  
 
Benedetti, Victor & Hope and Johansson reported a higher incidence of 
alcoholism in the families of patients with alcohol hallucinosis than in the 
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general population.  Benedetti also found a family history of schizophrenia in 
relatives of patients with alcohol hallucinosis to be more common than in the 
general population, but less common than in relatives of patients with 
schizophrenia. This was different to Scott et al who reported a similar 
incidence in schizophrenia in the relatives of patients with alcohol hallucinosis 
to that in the general population. Schuckit and Winokur (1971) could not 
distinguish patients with alcohol hallucinosis (n=61) on grounds of a prior 
history of schizophrenia in or a higher incidence of schizophrenia in their 
families when comparing them with a group of alcoholic patients without 
hallucinosis.  Likewise Schuckit (1982) again reported no association between 
the psychotic symptoms in alcoholic patients (n=220) and a personal or family 
history of schizophrenia.  
 
Kendler et al (1985) reported that alcoholism is significantly less common in 
first degree relatives of patients with schizophrenia than in the relatives of 
controls.  In a twin study, Kendler (1985) found that schizophrenia and 
alcoholism alone and in combination were more common in monozygotic than 
in dizigotic twins.  This suggests that patients with alcoholism and 
schizophrenia have a predisposition to each disorder separately.   
 
Kendler further reported that alcoholic psychosis was significantly more 
common in monozygotic (32%) than dizygotic (13%) index twins.  He also 
reported no significant difference in the frequency of schizophrenia or 
alcoholism in the co-twins of index twins, with or without a diagnosis of 
alcoholic psychosis.       
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Soyka (1990) (see earlier text) demonstrated that patients with schizophrenia 
significantly more often reported a positive family history for schizophrenia 
compared to patients with alcohol hallucinosis who were significantly more 
likely to have a positive  family history for alcoholism.  
 
Hrubec & Omenn (1981) reported on the concordance for alcoholism (26.3% 
vs. 11.9%), alcoholic psychosis (21.1% vs. 6%), and liver cirrhosis (14.6% vs. 
5.4%) in monozygotic and dizygotic twins respectively. These results support 
a genetic predisposition for and separate transmission of organ specific 
vulnerabilities to alcohol damage.        
              
In summary, Glass, (1989b) concluded that these studies do not support a 
genetic predisposition to schizophrenia in patients with alcohol hallucinosis.  
More likely,  these results rather suggest a genetic vulnerability to the 
psychotogenic effect of alcohol in some patients with alcoholism and lends 
further support to the concept of alcohol-induced psychotic disorder as an 
independent disorder.      
           
1.5.2   Brain Imaging Studies   
1.5.2.1  Neuroimaging in Alcoholism 
Although regional cerebral blood flow (rCBF) increases in most brain areas 
during acute alcohol intake in normal individuals (Newlin 1982),  early studies 
generally showed decreased flow in gray and white matter areas in subjects 
with chronic alcoholism and alcohol amnestic disorder (Rogers et al., 1983, 
Meyer et al 1985, Ishikawa et al., 1986) Most SPECT neuroimaging studies 
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have shown reduced cerebral and particularly decreased frontal lobe blood 
flow in alcohol dependence as reviewed by Moselhy et al (2001).  SPECT 
studies by Melgaard et al (1990) and Nicolas et al (1993) reported that 
hypoperfusion was significantly correlated with impaired neuropsychological 
performance in patients with alcoholism.  Frontal hypoperfusion in chronic 
alcoholics did however not necessarily correlate with cortical atrophy as 
determined by computerized tomography (CT), because impaired rCBF was 
also demonstrated without atrophy (Erbas et al, 1992). Nicolas et al (1993) 
confirmed the usefulness of rCBF as a better indicator of neuropsychological 
function than the degree of atrophy in patients with alcoholism.   
 
Positron emission tomography (PET) studies also supported the view that 
chronic alcohol intake results in impaired cerebral function particularly in the 
medial frontal region (Adams et al 1993) and superior medial aspects of the 
frontal lobes (Gilman et al 1996).  Brain glucose metabolism as measured 
with PET recovered significantly in frontal regions during early abstinence, 
whereas persistent low metabolic levels were reported in the basal ganglia 
(Volkow et al, 1994). Similarly, George et al (1999) reported that multiple 
detoxifications were associated with significantly lower activity in temporal 
lobes and visual cortex compared with first episode patients, whilst Ishikawa 
et al (1986) and Gansler et al (2000) concluded that frontal brain perfusion 
abnormalities may subside with extended abstinence.    
 
Berglund & Risberg (1981), using the Xenon 133 inhalation method and 
Caspari et al (1993), using SPECT with technesium-99-HMPAO, reported 
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heterogeneous regional activity in patients with alcohol withdrawal.   
Increased functional activity in portions of the temporal cortex with decreased 
functional activity in other portions of the temporal and parietal cortex were 
reported.   Furthermore,  Bartsch et al (2007) reported spatially significant 
brain volume gain around the superior vermis, perimesencephalic, 
periventricular and frontal brain edges in patients after short-term (6-7weeks) 
sobriety  from alcoholism, utilizing MR morphometry along with metabolic and 
neuropsychological indicators.  These findings were not attributed to 
rehydration only, but implied metabolic as well as morphological (especially 
white matter) partial recovery from the toxic effects of alcoholism.              
 
1.5.2.2 Functional Neuro-imaging in Alcohol-induced Psychotic Disorder 
Information concerning brain imaging in alcohol-induced psychotic disorder is 
limited and mainly consists of case reports.  To date, we are not aware of any 
longitudinal studies utilizing clinical correlates and  functional neuroimaging in 
alcohol-induced psychotic disorder.  
 
Soyka et al (2000a, 2000b, 2005) reported Fluorodeoxyglucose (FDG) PET 
data in four patients suffering from alcohol hallucinosis that suggest possible 
thalamic dysfunction in this syndrome. Glucose metabolism was reduced in 
both frontal regions (28-30%), both thalamic regions (50%) and cerebellum 
(36%) of one patient (Soyka et al 2000a).  In the other patient the right 
thalamus demonstrated less (10-18%) FDG uptake than the left thalamus 
(Soyka et al 2000b).   Soyka et al (2005) also described marked left-to-right 
and right-to-left assymmetry showing hypometabolism in both thalamic 
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regions in two other patients with alcohol hallucinosis. Improvement of right 
thalamic metabolism was demonstrated 4 weeks later in the symptom-free 
abstinent patient.        
 
Kitabayashi et al (2007) reported decreased rCBF in the frontal lobe, left basal 
ganglia and left thalamus of a 56-year old patient with alcohol-induced 
psychotic disorder prior to treatment, using N-isopropyl-p-¹²³I 
iodoamphetamine (¹²³I-IMP) single photon emission computed tomography 
(SPECT).  After treatment with diazepam and haloperidol (6mg/day) and 
subsequent disappearance of hallucinations, the rCBF normalized in the left 
basal ganglia and left thalamus, but decreased flow in the frontal lobe 
remained. These findings suggest that hypofrontality may represent the long-
term effects of alcohol dependence whilst normalization of rCBF in the left 
thalamus and left basal ganglia could represent dysfunction in these areas 
that may be associated with the development of alcohol-induced psychotic 
disorder.      
     
1.5.2.3 Brain Imaging in Schizophrenia 
Lateral and third ventricular enlargement and cortical volume reduction of the 
brain as shown on Computed Tomography (CT) of the brain in patients with 
schizophrenia have been well documented and provided some of the earliest 
evidence that schizophrenia is a brain disease. (Weinberger et al, 1979a, 
1979b, 1982). Magnetic Resonance Imaging (MRI) has shown that the 
volumes of the amygdala complex and parayhypoccampal gyrus of the 
temporal lobe are also reduced in patients with schizophrenia (Bogerts et al, 
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1993). In a meta-analysis review by Honea et al (2005), only two areas of the 
50 areas where volume deficits were reported in schizophrenia, reported 
deficits in more than 50% of the 15 investigated morphometric studies. These 
areas were the left superior temporal gyrus and the left medial temporal lobe.   
Longitudinal studies have also reported progressive brain volume loss in 
patients with schizophrenia.  These changes appeared to be particularly 
evident in the frontal lobes (Ho et al, 2003, DeLisi et al, 2006).         
  
Positron Emission Tomography (PET) and Single Photon Emission Computed 
Tomography studies have demonstrated both impairment (hypofrontality) 
(Brodie et al 1984, Wolkin et al 1985, Lewis et al 1992, Andreasen et al 1992) 
and increase (hyperfrontality) (Volkow et al 1986, Wiesel 1987, Szechtman et 
al 1988, Catafau et al 1994) of frontal regional cerebral blood flow (rCBF) and 
regional glucose metabolism in patients with schizophrenia (Sabri et al, 1997).  
Similarly inconsistencies were reported from studies that demonstrated 
increased (Brodie et al 1984, Wolkin et al 1985) and decreased (Sheppard et 
al 1983) metabolism in the basal ganglia.  Hypoperfusion of the temporal 
lobes were reported in a number of studies (Crow 1990, Paulman et al 1990, 
Catafau et al 1994) especially of the left temporal lobe (Klemm et al 1996).           
 
Studies that investigated the correlation of regional cerebral blood flow 
abnormalites with psychopathology in schizophrenia revealed interesting 
results (Gur et al 1995; Erkwoh et al 1999). Statistically significant correlations 
were found between negative symptoms of schizophrenia and left frontal 
hypoperfusion and between positive symptoms and left temporal 
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hypoperfusion (Liddle et al 1992 Klemm et al 1996).  Of particular interest are 
the studies that investigated the correlation between hallucinations and rCBF.  
Silbersweig et al (1995) reported a number of areas associated with increased 
brain activity and auditory hallucinations. These areas included the thalamus 
(bilateral), the right putamen and the left parahippocampal gyrus.  
Hallucinations also correlated negatively to regional cerebral blood flow to the 
left thalamus in never treated patients with acute schizophrenia (Sabri et al, 
1997).   
 
Some of the observed changes are not necessarily specific for schizophrenia 
and similar changes have been reported in other neuropsychiatric disorders. 
Substance abuse is one factor that needs to be considered as being 
responsible for some of the brain changes seen in schizophrenia studies. 
Studies that excluded subjects with substance abuse, were however 
consistent with brain imaging findings in other schizophrenia studies. (DeLisi, 
1999).    
 
Brain imaging often has limited value in the diagnostic workup of patients 
presenting with psychosis. Clinically it is however often useful to rule out 
structural brain lesions associated with general medical condtions. It may also 
provide supportive evidence in patients presenting with schizophrenia.   
Notwithstanding its current clinical limitations, brain imaging is an invaluable in 
vivo research tool in neuropsychiatry.    
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1.6   Summary of Current Knowledge of the Syndrome  
Although Glass (1989) concluded that there is no concensus view relating to 
the nature of the disorder, she acknowledged that it does exist.  Both DSM IV 
and ICD-10 have diagnostic categories that accept the existence of the 
disorder.  (See Appendix A and Appendix B).  
 
1.6.1  Etiology 
The relationship of this disorder with the degree of alcohol dependence, 
physical impairment and cognitive dysfunction is uncertain.  
 
Evaluation of familial and genetic factors showed that psychotic symptoms in 
alcohol dependent individuals are unlikely related to a genetic predisposition 
to schizophrenia. This corresponds to Cutting’s opinion that alcohol induced 
psychosis should be viewed as a general medical related disorder rather than 
functional psychosis such as schizophrenia.  A further conclusion is that the 
vulnerability of certain alcohol dependent individuals to the development of 
psychosis is probably genetically determined.  No studies have thus far been 
able to explain the development of psychotic symptoms in patients with a 
history of alcoholism.  
 
1.6.2 Epidemiology 
 In South Africa the proportion of the population using alcohol was found to be 
low (44.7% men; 16.9% women) in comparison with most developing 
countries.  Life-time alcohol related problems were however reported as 
substantial (27.8% men ; 9.9% women) and many of those that drink reported 
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risky drinking especially over weekends (32.8% men; 32.4% women) (Parry, 
2005).     
 
Unfortunately the epidemiological data for alcohol-induced psychotic disorder 
are limited.  No local figures are available. Whereas the lifetime risk for 
alcohol dependence is 10-15% for males and 3-5% for females Schuckit 
(2005), only about 3% of patients with alcoholism have auditory hallucinations 
or paranoid delusions associated with heavy drinking or withdrawal. These 
figures however do not exclude patients with alcohol-withdrawal delirium. It is 
estimated that the alcohol-induced psychotic disorder patients represent a 
minority of this group (Soyka, 1988).  It may however also be possible that a 
percentage of patients with alcohol-induced psychotic disorder receive other 
diagnoses eg. “dual diagnosis”,  alcohol-withdrawal delirium etc. which may 
imply underreporting of this disorder.   
 
1.6.3  Clinical Presentation 
DSM IV specifies that the onset of symptoms should be within a month of 
alcohol intoxication or withdrawal.  The most common symtoms are auditory 
hallucinations, usually in the form of derogatory or threatening voices, 
delusions, often of a paranoid nature accompanied by anxiety.  These may be 
associated with suicidal behaviour, with or without depressive features.   
Symptoms occur in a clear sensorium.  Reality testing is usually impaired 
during the acute episode and most people regain insight after the 
hallucinations have subsided. Symptoms may occur at any age, but more 
often in patients who have abused alcohol for a long time.    
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1.6.4  Management 
Patients who develop alcohol-induced psychotic disorder usually require 
hospitalization, often due to the risk of suicide.  The disorder is an indication 
for the use of anti-psychotic medication.  However, no clinical trials have 
objectively assessed their efficacy.     
 
1.6.5  Course & Prognosis 
The initial episode is usually acute lasting days or weeks.  A chronic course 
may develop with exacerbations increasing in frequency. Abstinence from 
alcohol usually leads to remission, but not neccesarily. The risk of relapse is 
thus high in the presence of ongoing abuse. Generally the prognosis is 
however better than that of schizophrenia.  (Soyka, 1990) 
 
1.7  Problem Statement   
As mentioned earlier, there is concensus in the literature that alcohol-induced 
psychotic disorder exists as a separate entity.  Although much has been 
reported about the phenomenological aspects of psychopathology, very little 
has been reported about the pathogenesis and neurobiology. This include 
limited availability of neuro-imaging case reports and to our knowledge no 
documented neuro-imaging studies.  Case reports have suggested decreased 
metabolism in cortical and subcortical brain areas with specific involvement of 
the thalumus, basal ganglia and frontal lobes in patients with alcohol-induced 
psychotic disorder (Soyka et al 2000a, 2000b, 2005 and Kitabayashi et al 
2007).  Neuroimaging of the brain in patients with alcohol dependence 
suggests reduced regional cerebral blood flow in the frontal and temporal 
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lobes (reviewed by Moselhy et al, 2001). Furthermore, many reports on 
alcohol-induced psychotic disorder have lacked standardized methods and/or 
were characterized by methodological deficits.     
 
With this background, it is evident that a prospective comparative research 
design with standardized research measures focussing on a combination of 
psychopathological and neurobiological measures would serve as a useful 
way of exploring the nature of this disorder.  In addition, there is a need for a  
standardized methodological research design. In this respect, one of the 
needs would be to ensure relatively pure population groups under 
investigation.  These would include specific clinical measures to rule out 
comorbid pathology suc as substance abuse, head injuries, neurosyphillis etc.  
A longitudinal repeated-measure research design that correlates 
psychopathology measurements with radioimaging as has been utilized in a 
number of schizophrenia studies would satisfy these requirements.      
 
 
 
 
 
 
 
 
 
 
 40
2.    AIMS OF THE STUDY   
The overall aim of this study was to prospectively investigate demographic, 
clinical (including psychopathological) and brain-imaging aspects in patients 
with alcohol-induced psychotic disorder and to compare these variables in 
comparative groups namely, patients with (ii) acute signs of schizophrenia 
(including hallucinations), (iii) uncomplicated alcohol dependence and (iv) 
healthy volunteers. 
 
2.1 Objectives 
Specific objectives were as follows: 
First objective:  To compare all four population groups ie. patients with 
alcohol-induced psychotic disorder, schizophrenia, uncomplicated alcohol 
dependence and the healthy volunteer group according to demographic and 
psychopatological variables (utilizing rating scales). 
 
Second objective:  To assess and compare all four population groups ie. 
patients with alcohol-induced psychotic disorder, schizophrenia, 
uncomplicated alcohol dependence and healthy volunteer group, utilizing 
single photon emission computed tomography (SPECT) brain-imaging.  
  
Third objective:  To investigate the effect of standard anti-psychotic treatment 
(haloperidol) on psychopathology and regional cerebral perfusion (as 
assessed by SPECT) before and after treatment with haloperidol. Clinical 
assessments (including PANNS and other rating scales) were performed after   
completion of the study (6 weeks).   
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2.2  Hypothesis 
We postulated that: 
 (i) alcohol-induced psychotic disorder is a discrete clinical entity that can be 
differentiated from non-alcoholic, non-schizophrenic control subjects (healthy 
volunteers), schizophrenia and uncomplicated alcohol dependence  by means 
of standardised clinical assessment and SPECT imaging.   
 
We furthermore hypothesized that:  
(ii) changes in regional perfusion in patients with alcohol-induced psychotic 
disorder would be demonstrated in the basal ganglia, thalamus, frontal and  
temporal lobes.   
 
(iii)  clinical and brain imaging variables of alcohol induced psychotic disorder 
would normalize with anti-psychotic treatment and therefore shed light on the 
possible correlation between clinical symptoms and neuroanatomical 
dysfunction.  
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3.  METHODS  
3.1  Participants 
Patients with alcohol-induced psychotic disorder and schizophrenia were 
recruited from the acute psychiatric admission population of Stikland- and  
Tygerberg Hospitals.  Patients with alcohol dependence were recruited from 
Stikland Hospital prior to entering a rehabilitation programme, whilst healthy 
volunteers responded to local advertisements.   
 
Twenty-eight (n=28, F/M) patients with alcohol-induced psychotic disorder, 
twenty-one (n=21, F/M) with schizophrenia, twenty (n=20, F/M) with 
uncomplicated alcohol-dependence according to DSM criteria (American 
Psychiatric Association, 1994) and 19 healthy volunteers entered the baseline 
psychopathology component of the study.  Of these 9 patients with alcohol-
induced psychotic disorder and 5 with schizophrenia did not participate in the 
neuro-imaging-, SPECT-study component of the study. Nineteen patients with 
alcohol-induced psychotic disorder participated in the open treatment study 
component of the study.      
 
3.2   Study Components 
The psychopathology component of the study involved the baseline 
comparisons of (a) demographic and (b) general psychopatological variables 
amongst the four groups as outlined earlier as the first objective of the overall 
study.  The third section (c) reports on comparative psychopathology in 
alcohol-induced psychotic disorder and schizophrenia utilizing the PANSS 
rating scale, whilst the fourth section (d) comprises analysis of 
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psychopathological PANSS variables pre- and post-psychopharmacological  
treatment.             
 
The SPECT study component compared baseline SPECT variables 
between the four research populations namely alcohol induced-psychotic 
disorder, schizophrenia, alcohol dependence and healthy volunteers.  Pre- 
and post-treatment SPECT comparisons were also made in the alcohol-
induced psychotic disorder group.  Of note is that SPECT comparisons 
between groups were directed at specific brain areas as discussed and 
motivated earlier.  The specific areas under investigation were the frontal 
lobes, temporal lobes, basal ganglia and thalamus. 
 
The SPECT vs PANSS correlations component of the study compared 
psychological PANSS ratings and functional neuranatomical SPECT variables 
before and after an anti-psychotic treatment period of six weeks only in 
patients with alcohol-induced psychotic disorder.     Of note is that SPECT 
comparisons before and after treatment were not directed at specific brain 
regions as in the previous component of the study.  The effect of treatment 
allowed for assessment of all brain regions. A threshold of p<0.001 was 
utilized as level of statistical significance.       
 
3.3  Procedure 
All participants were interviewed with the Mini International Neuropsychiatric 
Interview (Version 4.4) (American Psychiatric Association, 1994, Sheehan et 
al 1998). Patients who met critria for another active DSM IV Axis I disorder, 
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including recent history of other substance abuse or dependence (excluding 
nicotine related disorders), were excluded from the study. Patients with 
schizophrenia with a history of alcohol (or any substance) abuse and/or 
dependence and patients with complicated alcohol dependence other than 
alcohol–induced psychotic disorder were also excluded from the study (eg. 
patients with alcohol-induced persistent dementia and alcohol-induced 
persisting amnestic disorder.)  Careful attention was therefore given to 
exclude patients with current alcohol-withdrawal or alcohol-withdrawal 
delirium in both the alcohol-dependent and alcohol-induced psychotic disorder 
groups. 
 
Written informed consent was obtained from all participants after the protocol 
had been ethically approved by the Research Committee of the Faculty of 
Medicine at the University of Stellenbosch.  A general physical clinical 
examination (including vital signs, blood pressure, pulse rate) was performed. 
Blood chemistry investigations, including urea and electrolytes, liver function 
tests, random glucose, full blood count and serology for syphilis were 
performed in the healthy volunteer group and where clinically indicated in the 
other groups. Urine sampling was randomly performed for alcohol and 
toxicological screening in all groups. Patients who had clinical significant 
medical or neurological disorders (including epilepsy and history of head 
injury) were excluded from the study.  Women (of child bearing age) were 
assessed for pregnancy and those with confirmed pregnancy and lactating 
mothers were not entered into the study. Patients were free to withdraw at any 
time during the course of the study.  
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All patients were required to undergo MRI scanning of the brain at the 
Magnetic Resonance Centre of the Christiaan Barnard Memorial Hospital, 
Cape Town, mainly to exclude major structural brain lesions. This is a non-
invasive, radiation free procedure.  Axial T2-weighted imaging was performed. 
If abnormal, these were followed by a fluid attenuated inversion recovery 
sequence (FLAIR).  MRI assessments were primarily utilized to exclude 
patients with clinical significant comorbid neurological conditions (such as 
space occupying or vascular lesions, eg infarcts) that would have required 
independent clinical intervention. Cortical atrophy was not an exclusion 
critrion unless accompanied by clinical significant cognitive impairment.  
These assessments were not compared as part of the study.   
 
Participants who used any psychotropic medication during the 10 days prior to 
the study (including alcohol and excluding benzodiazepines and/or cigarette 
smoking), or required  psychotropic medication during the course of the 
treatment study other than benzodiazepines, haloperidol and benzhexol (anti-
cholinergic agent) were excluded from the study.  A maximum of 4mg/day 
lorazepam equivalent was allowed during the treament study.   
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3.3.1  Rating scales and clinical research instruments  (See Appendix E) 
The following clinical research instruments were utilized and/or performed in 
all patient groups except where stated otherwise:   
 
Agitated Behavior Scale (ABS)  
This scale developed by Corrigan for assessment of agitated patients with 
traumatic brain injury was used in the alcohol-induced psychotic disorder   
and schizophrenia groups.  It has shown relative stability across samples of 
different diagnostic groups and has subsequently been utilized in 
schizophrenia studies. (Corrigan, 1989) 
      
Calgary Depression Scale for Schizophrenia (CDSS) 
The Calgary Depression Scale was designed for the assessment of 
depression in schizophrenia. It has been reported to be reliable and valid and 
does not overlap with negative or extrapyramidal symptoms. (Addington et 
al,1993) 
 
Clinical Global Impression of Severity of Psychosis (CGI-SP)   
This is a 7-point scale reflecting global impression of severity of psychotic 
illness and was performed in the alcohol-induced psychotic disorder and 
schizophrenia groups.  (Guy, 1976).   
 
Hamilton Depression Rating Scale (Ham-D) 
This scale measures the degree of clinical depression. (Hamilton, 1960) 
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Hamilton Anxiety Rating Scale  (Ham-A) 
This is a scale for measuring the degree of anxiety. (Hamilton, 1959)  
 
Mini-Mental State Examination (MMSE) 
The mental status examination is a well established screening method for 
cognitive impairment.  (Folstein et al, 1975) 
 
Positive and Negative Syndrome Scale (PANSS)    
This standardized rating scale developed as research instrument in 
schizophrenia was the primary clinical measure of psychosis in the alcohol-
induced psychotic disorder and schizophrenia groups in this study.  The 30 –
item scale consists of seven items on a Positive subscale, seven items on a 
Negative subscale and the remaining 16 on a General Psychopathology 
subscale.  The PANSS is scored by adding the ratings for each subscale as 
well as summation of ratings accross subscales to determine a total score. 
(Kay et al, 1987)        
 
Scale of Functioning (SOF) 
This is a well validated 15-item scale assessing multi-dimensional social 
functioning in areas such as particiapation in structured activities, socialization 
and financial management in patients with schizophrenia. (Rapaport et al, 
1996)     
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Scale to assess unawareness of mental disorder (SUMD) 
A subset of 6 items of this multidemensional scale was used to assess insight 
into illness in the the alcohol-induced psychotic disorder and schizophrenia 
groups: This scale has been reported to be a reliable and valid research 
instrument especially in patients with schizophrenia. (Amador et al, 1993)   
 
Severity of Alcohol Dependence Questionnairre (SADQ) 
This 27-item self-report questionnairre was utilized to assess severity of 
alcohol dependence in the two alcohol groups.  Results have indicated that 
the SADQ is a reliable and valid instrument for the assessment of the degree 
of alcohol dependence. (Stockwell et al, 1979, 1983).       
 
3.3.2  Functional Brain Imaging (SPECT) 
All patients (including the age matched healthy volunteer group) underwent   
single photon emission computerized tomography (SPECT) at the start of the 
study. The alcohol-induced psychotic disorder group had a similar SPECT 
study after completion of 6 weeks of haloperidol treatment.  SPECT of the 
brain, using the functional brain imaging agent technetium-99m (Tc-99m) 
hexamethyl amine oxime (HMPAO) was performed according to a 
standardised protocol, routinely used at our institution.   
 
Tc-99m HMPAO is a highly lipophilic substance, which rapidly crosses the 
blood-brain barrier to be taken up by the neurones.  The neuronal uptake is 
directly proportional to regional cerebral blood flow (rCBF) over a wide range 
of flow rates.  It has been shown that rCBF is directly related to regional 
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cerebral metabolic rate (Sokoloff L, 1981).  After the substance enters the 
neurones it is converted to a hydrophilic substance, which is then trapped 
within the neurones.  Subsequent imaging of the distribution of the radioactive 
tracer in the brain provides information about regional cerebral blood flow and, 
indirectly, about regional cerebral metabolism.  
 
3.3.2.1   Patient preparation 
An intravenous cannula was placed in an arm vein and a solution containing 
200mg sodium perchlorate was administered orally to minimise uptake of 
free pertechnetate by the salivary glands. Patients then remained 
comfortably in the supine position with their eyes open in a quiet, dimly lit 
room for 30 minutes.  This was done to achieve a basal cerebral metabolic 
state.  After completion of the 30 min rest period, a dose of 555 MBq of Tc-
99m HMPAO was injected through the intravenous cannula.  The patients 
were then required to remain in the resting state for a further 10 min to allow 
for uptake of the radiopharmaceutical in the brain.  
 
3.3.2.2   Data acquisition 
Patients were required to lie completely still on the imaging table, in the 
supine position, with the head supported by a headrest.  The patient’s head 
was lightly strapped to the headrest to ensure absence of head movement 
during data acquisition. SPECT imaging then commenced employing a 
standard clinical imaging protocol, using a dual detector gamma camera 
(Elscint Helix, GE Medical Systems,USA) equipped with fan beam 
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collimators.  Data were acquired utilising a circular orbit through 360° with 
the camera in the step-and-shoot mode. One hundred and twenty images 
were acquired using a 128 x 128 matrix, in 3° steps at 15s per step.  Raw 
images were inspected to ensure that no patient movement had occurred 
during the acquisition, in which case images were repeated. The radius of 
rotation and height of the imaging table were noted for each patient and 
used for the post-treatment study.      
 
3.3.2.3   Image reconstruction 
Data were reconstructed by filtered backprojection, using a Metz filter 
(power=5, FWHM=14mm). The Chang method (μ = 0.11/cm) was used for 
attenuation correction [Chang 1978]. The final reconstructed voxel size was 
1.7x1.7x3.9 mm3. Image files were converted from interfile to analyze format 
using conversion software (Medcon, Erik Nolf, UZ Ghent, Belgium). 
 
3.3.3   Treatment Study 
After baseline clinical assessments, which included MRI and SPECT imaging, 
patients with alcohol-induced psychotic disorder (n=20) were started on a 
daily dose of 5mg haloperidol (orally) and were maintained on this dose 
throughout the study. Extrapyrimidal side–effects, which were reported 
infrequently, were treated with benzhexol 2-6 mg/day and lorazepam 2-
4mg/day was used if required for sedation or anxiety.   Patients were clinically 
re-assessed after 3 weeks and at completion of the study (6 weeks).  This 
included a follow-up SPECT study. 
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3.4  Statistical Analysis 
 
3.4.1  Statistical Analysis: Psychopathology study component 
Comparisons of the four groups with respect to continuous variables like 
PANSS and other rating scales etc. were done by using analysis of variance 
(ANOVA) techniques. Depending on the nature of the observations, standard 
methods based on normal distribution theory were used where possible. 
Certain distribution-free techniques, like those based on rankings were 
implemented otherwise.  Where repeated measures were observed on each 
patient, the means were compared with either a paired t-test or if the data 
were not normally distributed, a Wilcoxin matched pairs test.   
 
When nominal variables were compared, it was done by utilizing contingency 
tables.  The maximum likelihood test rather than the Pearson chi-square test 
were used.  Reliability analysis/internal consistency for each of the PANSS 
(positive, negative and general) scales were determined by calculating 
Cronbach’s alpha coeficients.  Statistical analyses in this component of the 
study were performed with a significance level of 5% (p<0.05).    
 
3.4.2  Statistical Analysis: SPECT study components  
Statistical analyses were conducted on a voxel-by-voxel basis using Statistical 
Parametric Mapping (SPM2, Wellcome Department of Cognitive Neurology, 
UK) [Friston et al. 1991]. The images of each subject were normalised to the 
Montreal Neurological Institute (MNI) standard anatomical space with 4x4x4 
mm3 voxels, and to a value of 50 using proportional scaling. This was 
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achieved using 12 affine transformations and 7x8x7 non-linear basis 
functions. The normalised images were then smoothed using a 3D Gaussian 
kernel with a FWHM of 12mm. 
 
Analysis 
Four study designs were employed. Firstly an unpaired t-test was used to 
compare rCBF between different subject groups. Secondly a paired t-test was 
used to detect changes in rCBF in alcohol induced psychosis patients 
following pharmacotherapy. Thirdly in the alcohol induced psychosis patients 
correlations were sought between baseline rCBF and PANNS scores, and 
finally correlations were sought between changes in rCBF and changes in 
PANNS scores in the same group. 
 
To adjust for multiple comparisons an uncorrected p-value of p<0.001 was 
chosen as a threshold for statistical significance. A spatial extent threshold of 
10 voxels was also used at all times.  The first two analyses are also reported 
for an uncorrected p-value of p<0.01 in a number of regions determined a-
priori to be likely to be involved in the pathophysiology of alcohol induced 
psychosis (frontal cortex, temporal cortex, basal ganglia, and thalami). 
Clusters were located to anatomical regions using MRIcro software (Chris 
Rorden, Nottingham University, UK). 
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4.  RESULTS and DISCUSSION 
Note:  In order to preserve clarity and continuity,  the discussion of each 
component of the study will follow immediately after the results.    
 
4.1 Psychopathology  Study Results  
4.1.1 Demographics (See Tables 1 & 2)  
The mean age, gender ratio and ethnic distribution were similar in all groups. 
The gender ratio and ethnic distribution reflects the demographics of the 
clinical population of patients with alcohol-induced psychotic disorder that was 
referred from our catchment area over the course of the study.  Patients from 
the other groups were matched with the alcohol-induced psychotic disorder 
patient cohort based on age, gender and ethnicity.  The alcohol-induced 
psychotic disorder group differed significantly with each of the other groups on 
the grade of education achieved (p<0.01) whilst no significant (p>0.05) 
differences were noted amongst the other 3 groups.      
 
According to the histories obtained, patients with alcohol-induced psychotic 
disorder  presented with the first onset of psychosis at a much later age than 
patients with schizophrenia (mean age: 36.22 vs.24.79 yrs; p<0.01). No 
statistical difference was found with regard to the age of onset of alcohol 
related symtoms amongst the two groups of patients with alcohol related 
symptomatology (mean age: 21.39 vs. 20.25 yrs; p=0.46).  Although strong 
evidence of suicidal behaviour (attempts) was reported by the three patient 
groups, no statistical significant differences could be demonstrated.                
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Table 1: Demographic characteristics of the four study groups. 
 
 Alcohol- 
Induced 
Psychotic 
Disorder 
(n=28) 
 
Schizophrenia 
 
(n=21) 
 
Alcohol 
Dependence 
(n=20) 
 
Healthy 
Volunteers 
(n=19) 
 
 
p values 
 
Age 
(Mean/Range) 
 
 
38.09 (23-51) 
 
35.24 (19-55) 
 
37.60 (24-54) 
 
38.14 (23-56) 
 
p=0.565 
(AN) 
 
Gender 
 
 
 M23/F5 
 
M15/F6 
 
M17/F3 
 
M14/F5 
 
p=0.659 
(CHI) 
 
Educational 
level (grade) 
 
             
7.71 
             
10.85 
             
10.55 
 
 
11. 89 
 
p<0.0001 
(KW) 
 
 
Ethnicity 
 
 
B26/W2/A0 
 
B14/W6/A1 
 
B16/W3/A1 
 
B16/W3/A0 
 
p=0.257 
(CHI)  
(Key to abbreviations: p values: AN=ANOVA; CHI=Likelihood ratio chi-square; KW= Kruskal- 
Wallis; MW=Mann-Whitney. Ethnicity: B=Brown; W=White; A=Black African) 
 
 
Table 2: Histories of age of onset of illness and suicidal behaviour 
 
 Alcohol- 
Induced 
Psychotic 
Disorder 
(n=28) 
 
Schizophrenia
 
(n=21) 
 
Alcohol 
Dependence 
(n=20) 
 
Healthy 
Volunteers 
(n=19) 
 
 
p values 
Age at onset 
of first 
psychotic 
symptoms 
(yrs) 
 
 
36.22(23-50) 
 
 
24.79(19-36) 
 
 
N/A 
 
 
N/A 
 
 
p<0.01  
(AN) 
Age at onset 
of alcohol  
related 
symptoms 
(yrs) 
 
 
21.39(12-39) 
 
 
N/A 
 
 
20.25(14-38) 
 
 
N/A 
 
 
p=0.46 
(MW) 
History of 
suicidal 
behaviour 
 
n=10/28 
(35.7%) 
 
n=4/21  
(19.0%) 
 
n=6/20 
(30%)  
 
N/A 
 
p=0.42 
(CHI)  
(Key to abbreviations: p values: AN=ANOVA; CHI=Likelihood ratio chi-square; KW= 
Kruskal- Wallis; MW=Mann-Whitney.) 
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4.1.2  Psychopathology - general (see Table 3) 
Patients with clinically significant comorbid Axis I diagnoses such as major 
depressive disorder and anxiety disorders were excluded from this study. 
Nevertheless, patients with alcohol-induced psychotic disorder scored higher 
on anxiety and depressive symptoms compared to patients with 
schizophrenia, alcohol dependence and healthy volunteers.  For the anxiety 
ratings on the Ham-A this reached statistical significance (p<0.01) compared 
to the schizophrenia group and healthy volunteers.  With regard to depressive 
symptoms, patients with alcohol-induced psychotic disorder scored 
significantly higher on the Ham-D in comparison to patients with alcohol 
dependence and healthy volunteers, but not when compared with the 
schizophrenia group.  However when depressive symptoms were assessed 
by the CDSS, statistical significance was achieved when compared to the 
schizophrenia group, but not with the alcohol-dependent group.           
 
Mild cognitive impairment in the alcohol-induced psychotic disorder group was 
suggested by their mean score (27.96) on the MMSE which differed 
significantly from the alcohol dependent group (29.55; p<0.01) and healthy 
volunteers (29.79; p<0.01), but not from the schizophrenia group (28.76; 
p=0.52).       
 
When comparing the severity of drinking in the two alcohol-related groups, it 
was interesting to note that the alcohol-dependent group scored significantly 
higher on the SADQ (38.45 vs. 25.92; p<0.01) compared to the alcohol-
induced psychotic disorder group.  There was however no significant 
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difference in the onset of general alcohol related symtoms between the two 
alcohol related patient groups.    
 
 A number of different measurement parameters suggested that patients with 
schizophrenia presented with more severe and disabling impairment than 
those with alcohol-induced psychotic disorder. Not only does the psychotic 
syndrome differ in severity on the CGI-SP (4.62 in schizophrenia group vs. 
3.68 in alcohol-induced psychotic disorder group;p<0.01),  but impairment of 
functioning as measured on SOF, is likewise more pronounced in the 
schizophrenia group (38.23 vs. 46.80; p<0.01) than in the group with alcohol-
induced psychotic disorder.  As may have been expected both psychotic 
disorder patient groups differed significantly from the alcohol dependant group 
in terms of agitated behaviour as measured on the ABS.  Furthermore, the 
scores (18.86 in alcohol-induced psychotic disorder group vs. 31.95 in 
schizophrenia group; p<0.01) on the SUMD support the impression that 
patients with alcohol-induced psychotic disorder have a greater awareness of  
their illness as compared to patients with schizophrenia.      
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Table 3: Psychopathology - general 
Mean Scores ±SD   
 
Rating Scale 
Alcohol- 
Induced 
Psychotic 
Disorder  
(n=28) 
 
Schizophrenia
 
(n=21) 
 
Alcohol 
Dependence 
(n=20) 
 
Healthy 
Volunteers 
(n=19) 
 
p values/ 
Bonferroni 
comparisons
Hamilton 
Anxiety 
Scale 
 
11.14±7.20 
 
5.67±3.41 
 
8.30±4.50 
 
1.89±1.80 
 
a,d,e,h,j,k 
Hamilton 
Depression 
Scale 
 
12.46±6.88 
 
9.67±2.71 
 
7.70±3.87 
 
1.10±1.33 
 
b,c,e,h,i,k 
Calgary 
Depression 
Scale 
 
4.64±4.14 
 
1.76±1.84 
 
3.80±1.88 
 
0.26±0.56 
 
a,d,e,h,j,k 
Mini Mental 
State 
Examination 
 
27.96±2.44 
 
28.76±1.30 
 
29.55±0.83 
 
29.79±0.54 
 
b,c,e,h,j,l 
Agitated 
Behavior 
Scale 
(Corrigan) 
 
18.46±2.55 
 
20.1±3.11 
 
15.45±1.47 
 
N/A 
 
b,c,g 
Scale of 
Functioning 
 
 
46.80±5.71 
 
38.23±6.17 
 
54.11±3.86 
 
58.78±0.85 
 
a,c,e,g,i,l 
Severity of 
Alcohol 
Dependence 
Questionnairre  
 
25.92±12.33 
 
N/A 
 
38.45±12.62
 
N/A 
 
p<0.01 
(AN) 
Scale to 
assess 
unawareness 
of mental 
disorder 
 
18.86±6.71 
 
31.95±9.17 
 
N/A 
 
N/A 
 
p<0.01 
(MW)  
Clinical Global 
Impression of  
Severity of 
Psychosis 
 
3.68±0.90 
 
4.62±0.97 
 
 
N/A 
 
N/A 
P<0.01 
(MW) 
 
 
Key to p values (Bonferroni):  
Alcohol-induced psychotic disorder vs. Schizophrenia: (a) p<0.01, (b) p>0.05;  
Alcohol-induced psychotic disorder vs. Alcohol dependence: (c) p<0.01, (d) p>0.05);  
Alcohol-induced psychotic disorder vs. Healthy volunteers: (e) p<0.01, (f) p>0.05; 
Schizophrenia vs Alcohol dependence: (g) p<0.01, (h) p>0.05 ;  
Schizophrenia vs Heathy volunteers: (i) p<0.01, (j) p>0.05 ;  
Alcohol dependence vs  Healthy volunteers: (k) p<0.01, (l) p>0.05.   
Key to abbreviations: p values: AN=ANOVA; MW=Mann-Whitney. 
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4.1.3  Psychopathology: Psychotic features in alcohol-induced 
psychotic disorder compared to those in schizophrenia  (Table 4) 
Only the patients from the alcohol-induced psychotic disorder and 
schizophrenia groups (i.e. patients with psychotic disorders) were included in 
this comparison on the PANSS rating scale. 
   
Patients with alcohol-induced psychotic disorder scored highly significantly 
(p<0.01) lower than those with schizophrenia on all three subscales as well as 
on total scores (19.89 vs. 24.38, on the positive subscale; 14.86 vs. 24.48, on 
the negative subscale; 35.68 vs. 42.67, on the general psychpatology 
subscale and 70.43 vs. 91.52 on the total scores).  
 
Positive symptom subscale:  
Internal consistency/reliability  on the positive subscale was relatively low  in 
the alcohol-induced psychotic disorder  group (Cronbach’s alpha = .41). This 
increased to .51 when the p3 Item (hallucinations) was deleted. This item was 
the only item on the positive subscale that was inversely correlated with the 
other positive subscale items in the alcohol-induced psychotic disorder group.  
Despite this, item p3 was included for further analysis, hallucinations being a 
core feature of both disorders.   
 
Three individual items of the positive subscale namely pos2 (conceptual 
disorganization) and pos5 (grandiosity) scored highly significantly (p<0.01) 
and  pos1 (delusions) significantly (p<0.05) lower in the alcohol-induced 
psychotic disorder group compared to the schizophrenia group. Only one item 
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namely  pos3 (hallucinations) scored significantly (p<0.05) higher in the 
alcohol-induced psychotic disorder group compared to the schizophrenia 
group. No statistical differences between the two groups were found on the 
following items: pos4 (excitement), pos 6 (suspiciousness) and pos7 
(hostility).     
 
Negative symptom  subscale:     
Internal consistency/reliability on the negative subscale was relatively high in 
the  combined population (Cronbach’s alpha = .90). 
 
Except for item neg5 (difficulty in abstract thinking), all items on the negative 
subscale rated highly significantly (p<0.01), [items neg1 (blunted affect), neg2 
(emotional withdrawal), neg3 (poor rapport), neg4 (passive/apathetic social 
withdrawal) and neg7 (stereotyped thinking)], or significantly (p<0.05), [item 
neg6 (lack of spontaneity and flow of conversation)], lower in the alcohol-
induced psychotic disorder group compared to the schizophrenia group.  
Overall, all mean scores for items on the negative subscale were lower in the 
alcohol-induced psychotic disorder  group.  
 
No statistically significant difference between the groups was  found on the 
following item: neg5 (difficulty in abstract thinking).  
 
General psychopathology subscale:   
Internal consistency/reliability on the negative subscale in the combined 
population was acceptable (Cronbach’s alpha =0.62).  
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Mean scores of  seven of the 16 items on the general psychopathology scale 
were either highly significantly (p<0.01), [items gen7 (motor retardation), gen9 
(unusual thought content), gen12 (lack of judgement and insight), gen13 
(disturbance of volition), gen15 (pre-occupation) and gen16 (active social 
avoidance], or significantlly (p<0.05) [item gen5 (mannerisms and posturing)], 
lower in the alcohol-induced psychotic disorder group when compared to the 
schizophrenia group.   Three items, [gen2 (anxiety), gen4 (tension), and gen6 
(depression)] scored significantly (p<0.05) higher in the alcohol-induced 
psychotic disorder group.      
 
No statistical differences between the two groups were found in the mean 
scores of the following items: gen1 (somatic concern), gen3 (guilt feelings), 
gen8 (uncooperativeness),  gen 10 (disorientation), gen11 (poor attention) 
and gen14 (poor impulse control).   
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Table 4 : Psychopathology - psychotic features 
 
 
PANSS 
positive scale 
Alcohol- Induced 
Psychotic Disorder 
(n=28) 
Mean ± SD 
 
Schizophrenia 
(n=21) 
Mean ± SD 
 
 
p values 
(MW) 
Pos1 3.93 ± 1.18 4.62 ± 1.02 p = 0.04 * 
Pos2 1.18 ± 0.39 4.14 ± 1.35 p < 0.01 ** 
Pos3 4.07 ± 1.02  3.29 ± 1.27 p = 0.02 * 
Pos4 2.82 ± 1.12 3.10 ± 1.14 p =0.38   
Pos5 1.36 ± 0.73 2.76 ± 1.51 p< 0.01 ** 
Pos6 4.11 ± 1.42 3.90 ± 1.45 p = 0.59 
Pos7 2.46 ± 0.92 2.52 ± 1.17 p = 0.87 
Positive Total    19.89 ± 3.31    24.38 ± 4.61 P< 0.01 ** 
 
PANSS 
negative scale  
Alcohol- Induced 
Psychotic Disorder 
(n=28) 
Mean ± SD 
 
Schizophrenia 
(n=21) 
Mean ± SD  
 
 
p values 
Neg1 1.61± 1.03 3.29 ± 1.06  p<0.01** 
Neg2 2.25 ± 1.04 3.90 ± 0.83  p<0.01** 
Neg3 1.61 ± 1.34  2.90 ± 1.26  p<0.01** 
Neg4 2.29 ± 1.15 4.19 ± 0.81  p<0.01**  
Neg5 3.21 ± 1.50 3.95 ± 1.66  p=0.13 
Neg6 2.04 ± 1.29 2.90 ± 1.45  p=0.03 * 
Neg7 1.86 ± 1.01 3.33 ± 1.11  p<0.01 ** 
Negative Total 14.86 ± 6.33 24.48 ± 6.01 P<0.01 ** 
 
PANSS 
general scale  
Alcohol- Induced 
Psychotic Disorder 
(n=28) 
Mean ± SD  
Schizophrenia 
(n=21) 
Mean ± SD  
 
 
p values 
Gen1 1.68 ± 1.16 2.48 ± 1.81  p=0.13 
Gen2 3.32 ± 0.86 2.62 ± 0.97   p=0.02 * 
Gen3 1.71 ± 0.98 1.48 ± 0.81 p=0.47 
Gen4 2.68 ± 0.77  2.10 ± 0.77  p=0.02 * 
Gen5 1.04 ± 0.19 1.57 ± 0.87  p=0.04 * 
Gen6 2.93 ± 1.46 1.95 ± 0.92   p=0.02 * 
Gen7 2.04 ± 1.29 3.24 ± 1.22  p<0.01** 
Gen8 1.54 ± 0.74 1.81 ± 0.87  p=0.28 
Gen9 2.96 ± 1.04  3.81 ± 0.93  p<0.01 ** 
Gen10 1.32 ± 0.72  1.52 ± 0.87  p=0.52  
Gen11 1.64 ± 0.91 2.05 ± 1.24  p=0.35  
Gen12 3.57 ± 0.88  4.67 ± 0.86  p<0.01 ** 
Gen13 2.18 ± 1.02 3.76 ± 0.94  p<0.01 ** 
Gen14 2.61± 1.10 2.71 ± 0.85 p=0.66  
Gen15 1.79 ± 0.96 3.19 ± 1.33 p<0.01 ** 
Gen16 2.71 ± 1.12  3.71 ± 0.85 p<0.01 ** 
General Total 35.68 ± 7.19 42.67 ± 5.79 p<0.01 **     
Total Score 70.43 ± 13.39 91.52 ± 12.65 p<0.01 ** 
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(*Significant p<0.05; and ** highly significant p<0.01) 
 
Symptom definitions: Positive subscale: pos1, delusions; pos2, conceptual disorganization; 
pos3, hallucinations; pos4, excitement; pos5, grandiosity; pos6, suspiciousness/persecution; 
pos7, hostility. Negative subscale: neg1, blunted affect; neg2, emotional withdrawal; neg3, 
poor rapport; neg4, passive/apathetic social withdrawal; neg5, difficulty in abstract thinking; 
neg6, lack of spontaneity and flow of conversation; neg7, stereotyped thinking. General 
Subscale: gen1, somatic concern; gen2, anxiety; gen3, guilt feelings; gen4, tension; gen5, 
mannerisms and posturing; gen6, depression,  gen7, motor retardation; 
gen8,uncooperativeness; gen9, unusual thought content; gen10, disorientaion; gen11, poor 
attention; gen12, lack of judgement and insight; gen13, disturbance of volition;  gen14, poor 
impulse control;  gen15, preoccupation; gen16, active social avoidance.     
 
Severity of symptoms on all subcales: (Table 5) 
All items on the PANSS rating scale are rated as follows:  1=absent, 
2=minimal, 3=mild, 4=moderate, 5=moderate severe, 6=severe and 
7=extreme.  Based on PANSS mean scores ratings ≥ 3, the following 
psychotic syndrome profiles emerged for each group: (see table 5). 
 
Patients with alcohol-induced psychotic disorder predominantly presented 
with delusions, hallucinations, suspiciousness, difficulty in abstract thinking, 
anxiety and lack of judgement and insight.  It is of particular interest that low 
mean scores (<2) on conceptual disorganization, grandiosity, blunted affect, 
poor rapport, stereotyped thinking, somatic concern, guilt feelings, 
mannerisms and posturing, uncooperativeness, disorientation, poor attention 
and pre-occupation, were noted in the alcohol-induced psychotic disorder 
group.  This suggests the virtual absence of these symptoms in this group.   
 
On the other hand, presenting symptoms (mean scores ≥ 3) in the 
schizophrenia group also included conceptual disorganization, excitement and 
negative symptoms such as blunted affect, emotional withdrawal, 
passive/apathetic social withdrawal and stereotyped thinking.  On the general 
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scale, motor retardation, unusual thought content, disturbance of volition, pre-
occupation and active social avoidance completed the expected 
schizophrenic syndrome. The general scale item with mean score ≥ 3 in the 
alcohol-induced psychotic disorder group not equaled in the schizophrenia 
group was anxiety.  
 
Table 5: Severity of symptoms (PANSS mean scores ≥3)  
 
 
PANSS item 
positive scale 
Alcohol- 
Induced 
Psychotic 
Disorder 
(n=28) 
Mean 
score 
 
PANSS item 
positive scale  
 
 
Schizophrenia 
(n=21) 
Mean score 
P1 (delusions)  
 
 
p3 (hallucinations)  
 
p6 (suspiciousness) 
3.93 
 
 
4.07 
 
4.11 
P1 (delusions)  
p2(conceptual                 
disorganization)  
p3 (hallucinations)  
p4 (excitement)  
p6 (suspiciousness) 
4.62 
4.14 
 
3.29 
3.10 
3.90 
PANSS item 
Negative scale 
 PANSS item 
Negative scale 
 
 
 
 
 
n5 (difficulty in abstract 
thinking) 
 
 
 
 
3.21 
N1 (blunted affect) 
n2 (emotional 
withdrawal) 
n4 (passive/appathetic 
social withdrawal) 
n5 (difficulty in abstract 
thinking) 
n7(stereotyped 
thinking) 
3.29 
3.90 
4.19 
 
3.95 
 
3.33 
PANSS item 
general scale 
 PANSS item 
general scale 
 
G2 (anxiety)  
 
 
g12 (lack of judgement 
and insight) 
3.32 
 
 
3.57 
G7(motor retardation)  
g9 (unusual thought 
content) 
g12 (lack of judgement 
and insight)  
g13 (disturbance of 
volition)  
g15 (pre-occupation)  
g16 (active social 
avoidance) 
3.24 
3.81 
 
4.67 
 
3.76 
 
3.19 
3.71 
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Five-factor analysis of the PANSS: (Table 6) 
Although originally designed with 3 subscales, several factor analytical studies 
of the PANSS have preferentially yielded  5 factors, namely  negative, positive 
(psychotic), disorganized, excited and depression and anxiety factors (Emsley 
et al, 2003).  We also compared alcohol-induced psychotic disorder to 
schizophrenia on the five-factor structure for schizophrenia.  Less specific 
items (n7, g1, g4, g5, g13 and g15) were excluded as these factors are 
believed not to significantly effect the PANSS factor structure (Emsley et al, 
2003).  Two factor components namely the negative factor component and 
the disorganized factor component scored highly significantly (p>0.01) lower 
in the alcohol-induced psychotic disorder group.  The scores on the 
excitement component did not differ significantly between the groups. With 
regard to the remaining factor components, the alcohol-induced psychotic 
disorder group scored significantly higher and lower than the schizophrenia 
group with regard to the depression/anxiety factor and psychosis factor 
components respectively.   
Table 6: Five-factor analysis of the PANSS 
  
  
 
Cronbach – 
alpha 
Alcohol- 
Induced 
Psychotic 
Disorder 
(n=28) 
Mean score
 
 
Schizophrenia 
(n=21) 
Mean score 
 
 
p values 
(MW) 
Psychosis factor  
(p1,p3, p5, p6, g9,g12) 
 
.53 
 
3.33 
 
3.84 
 
P<0.05 * 
Negative factor 
(n1,n2,n3,n4,n6,g7,g16) 
 
.93 
 
2.08 
 
3.45 
 
p<0.01 ** 
Disorganized factor 
(p2,n5,g10,g11) 
 
.60 
 
1.84 
 
2.92 
 
p<0.01 ** 
Excitement factor 
(p4,p7,g8,g14) 
 
.74 
 
2.36 
 
2.54 
 
P=0.41 
Depression/Anxiety 
factor 
(g2,g3,g6) 
 
.70 
 
2.65 
 
2.02 
 
P<0.05 * 
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4.1.4  Psychopathology in Alcohol-Induced Psychotic Disorder: PANSS 
ratings before and after anti-psychotic treatment  (Table 7) 
Wilcoxin’s matched pairs test (WILC) were used in all the analyses in Table 7 
since the repeated measurements were mostly not normally distributed. 
Highly statistically significant clinical improvements were noted on the positive 
(p<0.0001) and general psychopathology (p<0.001) subscales, as well as on 
the total score (p<0.001), of the PANSS.  No significant improvement (p<0.07) 
was measured on the negative symptom subscale of the PANSS.   
 
Positive symptom subscale 
Highly statistically significant improvements (p<0.01) were noted on five of the 
individual items of the positive symptom subscale. No significant improvement 
was evident on the pos2 (conceptual disorganization) and pos 5 (grandiosity) 
items.  Both of these items however scored extremely low (<2) at baseline 
suggesting no clinically significant psychopathology on these measures in 
patients with alcohol-induced psychotic disorder.    
     
Negative symptom subscale 
Statistically significant improvements (p<0.05) were evident on three of the 
individual items of the negative subscale, namely neg2 (emotional 
withdrawal), neg4 (passive/apathetic social withdrawal) and neg7 
(stereotyped thinking).  Low mean baseline scores (<3) on these three items 
however suggest only a mild degree of clinical severity.  Interestingly, no 
significant improvement was noted on the neg5 (difficulty in abstract thinking) 
item that showed the highest mean negative item score at baseline.  
 66
General psychopathology subscale  
Items that showed highly statistically significant improvements (p<0.01) on the 
general psychopathology subscale of the PANSS were the following: gen2 
(anxiety), gen4 (tension), gen6 (depression), gen9 (unusual thought content), 
gen 12 (lack of judgement and insight), gen14 (poor impulse control) and 
gen16 (active social avoidance).  Items gen11 (poor attention) and gen 15 
(pre-occupation) showed statistically significant improvement (p<0.05) after 
the six weeks of anti-psychotic treatment.  
Table 7:  Psychopathology in Alcohol-Induced Psychotic Disorder  
before and after anti-psychotic treatment 
 
PANSS 
positive scale 
Mean score 
before treatment 
n=20 
Mean score  
after treatment 
n=20
 
p values 
(WILC)  
Pos1 4.0 1.65 p<0.0001 **  
Pos2 1.15 1.00 p=0.11 
Pos3 3.95 1.35 p<0.001   ** 
Pos4 2.95 1.25 p<0.001   ** 
Pos5 1.30 1.10 p=0.18 
Pos6 4.20 1.15 p<0.001   ** 
Pos7 2.35 1.25 p<0.01     ** 
Positive Total 19.85 9.10 p<0.0001 
PANSS 
negative scale  
Mean score 
before treatment 
n=20 
Mean score  
after treatment 
n=20
 
p values 
(WILC) 
Neg1 1.35 1.30 p=0.83  
Neg2 2.05 1.45 p<0.05   * 
Neg3 1.40 1.25 p=0.55     
Neg4 2.25 1.45 p<0.05   * 
Neg5 3.20 2.65 p=0.06 
Neg6 1.65 1.55 p=0.79    
Neg7 1.65 1.20 p<0.05   * 
Negative Total 13.55 11.30 p=0.07 
PANSS 
General scale 
Mean score 
before treatment 
n=20 
Mean score  
after treatment 
n=20
 
p values 
(WILC) 
Gen1 1.65 1.30 p=0.36 
Gen2 3.25 1.70 p<0.001 ** 
Gen3 1.50 1.15 p=0.06 
Gen4 1.73 1.45 p<0.01   ** 
Gen5 1.05 1.00 p=0.06  
Gen6 2.65 1.55 p<0.01   ** 
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Gen7 1.70 1.60 p=0.79    
Gen8 1.30 1.05 p=0.09 
Gen9 3.00 1.25 p<0.001 ** 
Gen10 1.30 1.00 p=0.11  
Gen11 1.50 1.00 p<0.05   * 
Gen12 3.55 1.50 p<0.001 ** 
Gen13 1.95 1.65 p=0.25 
Gen14 2.40 1.15 p<0.01   **  
Gen15 1.75 1.05 p<0.05   * 
Gen16 2.55 1.50 p<0.01   ** 
General Total 33.70 20.90 p<0.001 **     
Total Score 67.10 40.85 p<0.001 ** 
 
Symptom definitions: Positive subscale: pos1, delusions; pos2, conceptual disorganization; 
pos3, hallucinations; pos4, excitement; pos5, grandiosity; pos6, suspiciousness/persecution; 
pos7, hostility. Negative subscale: neg1, blunted affect; neg2, emotional withdrawal; neg3, 
poor rapport; neg4, passive/apathetic social withdrawal; neg5, difficulty in abstract thinking; 
neg6, lack of spontaneity and flow of conversation; neg7, stereotyped thinking. General 
Subscale: gen1, somatic concern; gen2, anxiety; gen3, guilt feelings; gen4, tension; gen5, 
mannerisms and posturing; gen6, depression,  gen7, motor retardation; 
gen8,uncooperativeness; gen9, unusual thought content; gen10, disorientaion; gen11, poor 
attention; gen12, lack of judgement and insight; gen13, disturbance of volition;  gen14, poor 
impulse control;  gen15, preoccupation; gen16, active social avoidance.     
 
4.2  Discussion of Psychopathology Study  
This study not only supported the existence of alcohol-induced psychotic 
disorder as a discrete clinical entity, but also shed more light on demographic 
and psychopathological factors that have hitherto not been systematically 
assessed.   
 
Patients with alcohol-induced psychotic disorder first developed psychosis at 
an older age compared to patients with schizophrenia (Johansson, 1961; 
Glass, 1989).  This was confirmed by our study where the mean age of onset 
of psychosis was 36.22 years in the alcohol-induced psychosis group and 
24.79 years in the schizophrenia group.  This corresponds to the older mean 
age of onset of 37.4 years for alcohol-induced psychosis and 32.8 years for 
(paranoid) schizophrenia reported by Soyka (1990).   
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An interesting finding in our study was the distinct lower educational level 
found in the alcohol-induced psychotic disorder group when compared to  
alcohol dependent and schizophrenia patient groups. This does not seem to 
correspond to other variables that suggest better insight & judgement (on 
PANSS gen12 and SUMD),  lesser degree of psychosis (CGI-SP) and higher 
level of functioning (SOF) in the alcohol-induced psychotic disorder group 
compared to the schizophrenia group. Whether a lower educational level 
reflects a developmental deficit or vulnerability, or an external risk factor 
(other than alcohol) is uncertain.  
 
A greater degree of alcohol use, as suggested by Tsuang (1994), could have 
partially explained an increased vulnerability to the development of alcohol-
induced psychotic disorder, especially when occurring at a later age.  Life-
time alcohol use could have been greater in the in the alcohol-induced-                           
psychotic disorder group, but was not specifically assessed.  It must be noted 
though that the mean age (38.09 vs. 37.60yrs) and mean age of onset of 
alcohol related symtoms (21.39 vs. 20.25yrs) were neither statistically 
significantly different in the alcohol-induced psychotic disorder and alcohol-
dependence groups respectively. Accumulative exposure to the toxic effects 
of alcohol may however contribute to psychosis.  However, our findings do not 
support a greater degree of alcohol dependence in the alcohol-induced 
psychotic disorder group as measured on the Severity of Alcohol Dependence 
Questionairre (SADQ).  Given that this is a subjective rating instrument relying 
on the patient’s personal account of severity, further objective study including 
assessment of lifetime alcohol use  is warranted.  
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Tsuang (1994) also considered the possibility that concomitant abuse of 
other substances in patients with primary alcohol dependence may be a risk 
factor for the development of alcohol-induced psychotic disorder.  Once again, 
our findings do not support this.  We excluded all recent (< 6 months) and 
current substance abuse in all patient groups on the basis of personal and 
collateral histories as well as random toxicology screening prior to entering 
the study.  Comorbid substance abuse was thus highly unlikely to contribute 
directly to the development of psychotic symptoms in our patient cohort.  
 
The MMSE was primarily used as an instrument to exclude patients with 
clinically significant comorbid cognitive impairment in this study. Whilst it is 
acknowledged that it is not a sophisticated instrument for the assessment of 
cognitive impairment, our findings do indicate a mild degree of cognitive 
impairment in the alcohol-induced psychotic disorder patient group compared 
to healthy volunteers and to patients with alcohol dependence, but not when 
compared to patients with schizophrenia.  Whether factors such as substance 
abuse during early childhood or adolescence, possibly associated with a low 
level of education and mild cognitive deficit, predispose to the development of 
psychotic symptoms in later life is a theoretical possibility worth further 
exploration.  Of further interest may be to consider the protective factors 
allowing the delay of onset of psychotic symptoms until the third or fourth 
decades.   
 
Soyka (1988) reported a history of suicidal behaviour in 17.6% of patients 
with alcoholic hallucinosis.  This corresponds to the 35.7% of patients with 
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alcohol-induced psychotic disorder in our study that reported previous suicidal 
behaviour.  Whilst the groups did not differ statistically, suicidality remains a 
clinical significant entity in the clinical presentation and management of 
patients with alcohol-induced psychotic disorder.   
 
Comorbid anxiety and depressive symptoms in alcohol-induced psychotic 
disorder have also been reported previously (Soyka 1990). In this study these 
symptoms occurred significantly more in the alcohol-induced psychotic 
disorder group compared to the schizophrenia group.  The exclusion criteria 
disallowed patients with comorbid anxiety or depressive disorders, but no 
patients were excluded from this study on these grounds. Depressive and 
anxiety symptoms as measured on the PANSS improved along with psychotic 
features without anti-depressant intervention.  These symptoms therefore 
seem to occur as symptoms of alcohol-induced psychotic disorder or alcohol 
abuse rather than representing independent anxiety or depressive disorders.     
 
A number of important aspects with regard to the psychotic features of 
alcohol-induced psychotic disorder emerged from this study.  Firstly, it clear  
that patients with alcohol-induced psychotic disorder generally presented with 
significantly less severe psychotic features, better jugdement, insight 
and awareness of their condition and less functional impairment than 
patients with schizophrenia.  Alcohol-induced psychotic disorder appears to 
be devoid of specific  schizophrenic symptoms such as thought process 
disorder as suggested by the extremely low and highly significant difference 
from schizophrenia on the mean score on item pos2 (conceptual 
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disorganization). This is also supported by a highly significant difference on 
the disorganized factor component in the five-factor analysis.   Of special 
interest is the lower levels of negative symptoms, usually associated with 
schizophrenia, found in the patients alcohol-induced psychotic disorder. This 
is supported by the highly significant difference between the groups on the 
negative subscale of the PANSS, negative factor component of the five-factor 
analysis and individual items such as blunted affect (neg1). Symptoms 
suggestive of bipolar disorder (mania) such as grandiosity were also 
extremely remote. 
 
Interestingly, patients showed significant improvement with treatment on the 
positive, general and total scores but not on the negative scale of the PANSS.    
Symptoms associated with the psychotic syndrome (eg. hallucinations and 
delusions) and general symptoms (eg. anxiety and depressive features) as 
reflected by the positive and general subscales of the PANSS respectively, 
appear to be relatively reversible and possibly more representative of alcohol-
induced psychotic disorder itself.           
            
Identifying symptoms and signs that can be considered as typical of the 
alcohol-induced psychotic syndrome is not only of clinical importance, but has 
valuable research potential.  One set of symptoms and signs of alcohol-
induced psychotic disorder that may be of special interest when exploring the 
biological underpinnings of alcohol-induced psychotic disorder would be those 
that differ significantly from schizophrenia.  Secondly, it would be of similar 
importance to explore those symptoms and signs of alcohol-induced psychotic 
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disorder that show a consistent degree of severity and also respond to 
treatment.  These aspects comprised   the second and third components of 
our study and will be discussed in the next sections.   
 
4.3  SPECT Study Results. 
4.3.1  Demographics 
The demographic composition of the sample for this part of the study was 
similar to that of the psychopathology study.  The alcohol-induced psychotic 
disorder group consisted of 19 participants (15 male, 4 female) with a mean 
(SD) age of 39 (4) years; the schizophrenia group consisted of 16 
participants, (11 male, 5 female) with a mean (SD) age of 35 (10) years; the 
alcohol dependent group consisted of 20 participants (17 male, 3 female) with 
a mean (SD) age of 38 (7) years and the healthy volunteer group consisted of 
19 participants (14 male, 5 female) with a mean (SD) age of 37 (8) years.  All 
the participants included in this part of the study also participated in the 
psychopathology component of the study. The main reason for non-inclusion 
of patients from the original group in this part of the study was lack of 
informed consent.          
 
4.3.2  SPECT rCBF Results  
Note: Not all the results are reported for the same level of statistical 
significance in this component of the study.  Given the large number of 
independant variables arising from SPECT studies and the fact that a result 
with a level of significance of p<0.01 has a 1% rate of occurrence by chance, 
it is to be expected that some results will reflect type I errors. However in the 
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case of results with a level of significance of p ≤ 0.001, these errors are 
expected to be far less common.          
 
4.3.2.1  Regional Cerebral Blood Flow (rCBF) in patients with Alcohol-
Induced Psychotic Disorder vs Healthy Volunteers (comparing Frontal 
lobes, Temporal lobes, Basal ganglia and Thalamus) . 
  
The rCBF showed higher flow in all four anatomical regions investigated in 
patients with alcohol-induced psychotic disorder compared with healthy 
volunteers. Increased bilateral frontal and temporal lobe perfusion was noted 
as well as increased flow in the regions of the left thalamus and the right  
basal ganglia (Table 8).  No areas of reduced flow in these areas were noted 
in patients with alcohol-induced psychotic disorder.             
 
Table 8: rCBF higher  in patients with Alcohol-induced Psychotic 
Disorder compared to Healthy Volunteers.  
Cluster size 
(voxels) 
T p value MNI coordinates 
(x,y,z) 
Brain region 
48 3.69 p<0.001 16,52,8 Frontal Sup Medial R 
21 3.42 p<0.001 -44,0,24  Frontal deep to Pre-
central L  
51 3.33 p<0.01 16,-4,0 Pallidum R  
105 3.23 p<0.01 36,8,-28 Temporal pole Mid R  
34 3.17 P<0.01 -48,-48,0 Temporal Mid L 
37 2.97 P<0.01 -16,-12,-4 Thalamus L 
17 2.95 P<0.01 -24,48,8 Frontal Mid L 
16 2.8 P<0.01 48,-56,0 Temporal Mid R 
9 2.78 P<0.01 -44, 4, -28 Temporal Inf L  
5 2.58 P<0.01 -16,36,36 Frontal Sup L  
(Height thresholds: T=2.43, p=0.01 and for T=3.33, p=0.001)  
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4.3.2.2  Regional Cerebral Blood Flow (rCBF) in patients with Alcohol-
Induced Psychotic Disorder vs  patients with Schizophrenia (comparing 
Frontal lobes, Temporal lobes, Basal ganglia and Thalamus).  
 
These results were diverse and statistically significant differences were limited 
to the right mid-temporal region and the left inferior frontal lobe which showed 
higher and lower flow respectively in patients with alcohol-induced psychotic 
disorder in comparison to patients with schizophrenia. (Tables 9 & 10).      
 
Table 9:  rCBF higher  in patients with Alcohol-induced Psychotic 
Disorder compared to patients with Schizophrenia  
 
Cluster size 
(voxels) 
T p value MNI coordinates 
(x,y,z) 
Brain region 
32 3.31 p<0.01 52,-64,24  Temporal Mid R 
(Height thresholds: T=2.44, p=0.01 and for T=3.36, p=0.001)  
 
Table 10: rCBF lower in patients with Alcohol-induced Psychotic 
Disorder compared to patients with Schizophrenia.  
 
Cluster size 
(voxels) 
T p value MNI coordinates 
(x,y,z) 
Brain region 
10 3.44 p<0.001 -32,12,28 Frontal Inf Tri L  
(Height thresholds: T=2.44, p=0.01 and for T=3.36, p=0.001)  
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4.3.2.3  Regional Cerebral Blood Flow (rCBF) in patients with Alcohol-
induced Psychotic Disorder vs  patients with Alcohol Dependence 
(comparing Frontal lobes, Temporal lobes, Basal ganglia and Thalamus).  
These results suggest higher rCBF in the parahippocampal region of the left 
temporal lobe in patients with alcohol-induced psychotic disorder when 
compared with patients with alcohol dependence.  
 
It also showed comparatively reduced flow to components of three of the 
four anatomical brain regions, mainly to the left inferior and mid-frontal 
lobe, the left basal ganglia and to the mid-temporal lobes bilaterally. 
(Tables 11 & 12).             
 
Table 11: rCBF higher  in patients with Alcohol-induced Psychotic 
Disorder compared to patients with Alcohol Dependence.   
Cluster size 
(voxels) 
T p value MNI coordinates 
(x,y,z) 
Brain region 
8 2.73 p<0.01 -12,4,-20 Parahippocampal L 
(Height thresholds: T=2.43, p=0.01 and for T=3.33, p=0.001)  
 
Table 12: rCBF lower  in patients with Alcohol-induced Psychotic 
Disorder compared to patients with Alcohol Dependence.    
Cluster size 
(voxels) 
T p value MNI coordinates 
(x,y,z) 
Brain region 
103 4.09 p<0.001 -40,40,-4  Frontal Inf Orb L 
44 3.48 p<0.001 -20,16,-4 Putamen L 
17 3.29 p<0.01 -36,24,52 Frontal Mid L  
47 3.26 p<0.01 56,-44,-4 Temporal Mid R 
99 3.17 p<0.01 -56,-56,4 Temporal Mid L  
44 3.15 p<0.01 16,40.44 Frontal Sup R 
7 3.02 p<0.01 16,32,-20 Frontal Sup Orb R 
10 2.84 p<0.01 -44,20,20 Frontal Inf Tri L 
7 2.65 p<0.01 20,24,4 Caudate R  
(Height thresholds: T=2.43, p=0.01 and for T=3.33, p=0.001)  
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4.3.2.4  Regional Cerebral Blood Flow (rCBF) post vs pre treatment in 
patients with Alcohol-induced Psychotic Disorder (comparing Frontal 
lobes, Temporal lobes, Basal ganglia and Thalamus) .    
Anti-psychotic treatment did not appear to have a uniform effect on rCBF 
when comparing SPECT variables before and after a six week treatment 
period in patients with alcohol-induced psychotic disorder.  Areas of both de-
activation and activation were noted.  Post-treatment de-activation was 
detected mainly in the left frontal lobe and in the right temporal lobe (Table 
13).   Post–treatment activation was also mainly evident in the left frontal lobe 
(different clusters) and the left basal ganglia. (Table 14)  
 
Table 13:  De-activation of rCBF post vs pre therapy in patients with 
Alcohol-induced Psychotic Disorder.    
Cluster size 
(voxels) 
T p value MNI coordinates 
(x,y,z) 
Brain region 
12 3.19 p<0.01 -20,32,32 Frontal Sup L  
7 3.15 p<0.01 -20,52,-20 Frontal Mid Orb L 
5 3.11 p<0.01 40,-4,-20 Hippocampus R 
5 2.98 p<0.01 36,52,-12 Frontal Mid Orb R 
6 2.96 p<0.01 40,-20,-8 Hippocampus R 
5 2.76 p<0.01 -40,28,-16 Frontal Inf Orb L 
(Height thresholds: T=2.55, p=0.01 and for T=3.61, p=0.001)  
 
Table 14: Activation of rCBF post vs pre therapy in patients with  
Alcohol-induced Psychotic Disorder.    
Cluster size 
(voxels) 
T p value MNI coordinates 
(x,y,z) 
Brain region 
54 4.07 p<0.001 -8,0,68 Supplementary 
Motor Area L 
62 3.89 p<0.001 -12,16,12 Caudate L 
38 3.75 p<0.001 -48,-20,20 Rolandic Operculum 
L 
24 3.2 p<0.01 -24,-24,,64 Frontal Pre-central L 
8 3.08 p<0.01 0,-12,40 Cingulum Mid 
(Height threshold: T=2.55, p=0.01 and for T=3.61, p=0.001)  
 77
4.4  Discussion of SPECT Study   
Following the aims set out for this study, the SPECT results supported 
baseline differences of regional cerebral blood flow (rCBF) between patients 
with alcohol-induced psychotic disorder and healthy volunteers, patients with 
schizophrenia and patients with alcohol dependence respectively.   These 
differences were not demonstrated to the same level of significance and 
comparisons between the groups will be discussed separately.      
 
Differences in regional cerebral perfusion in patients with alcohol-induced 
psychotic disorder were postulated to be demonstrable in the basal ganglia, 
thalamus, frontal and temporal lobes on the basis of case reports by Soyka et 
al (2000a, 2000b, 2005) and Kitabayashi et al (2007).  Support for this was 
found in our study especially in the frontal and temporal lobes and basal 
ganglia with less convincing differences demonstrated in the thalamus.  The 
resting cerebral perfusion differences in these brain regions will be discussed 
along with changes noted before and after 6 weeks of anti-psychotic therapy.       
     
4.4.1 Regional cerebral blood flow in patients with alcohol-induced 
psychotic disorder vs healthy volunteers.   
 Unlike case reports suggesting reduced flow to various brain regions in 
alcohol-induced psychotic disorder (Soyka et al 2000a, 2000b, 2005 
Kitabayashi et al 2007),  this component of the current study points to the 
contrary.  The brain regions investigated showed significantly increased 
resting perfusion in patients with alcohol-induced psychotic disorder 
compared to healthy volunteers, particularly to the frontal and temporal 
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lobes (bilaterally) and the regions of the right pallidum and left 
thalamus.   
 
These findings are similar to reports on rCBF in alcohol withdrawal (Berglund 
& Risberg, 1981; Caspari et al, 1993) suggesting increased functional activity 
in portions of the temporal cortex in patients with alcohol withdrawal and  
lends some support to the hypothesis that alcohol-induced psychosis is a 
variant of alcohol withdrawal (Gross et al, 1968, 1970, 1972a, 1972b). 
Increased functional activity in the temporal lobes was also associated with 
auditory hallucinations in two patients with alcohol withdrawal (Berglund & 
Risberg, 1981).  Alcohol withdrawal was however also associated with 
decreased functional activity in other regions especially during the first two 
days of withdrawal (Berglund & Risberg, 1981). Heterogeneous regional 
activity was thus suggested implying increased activity in some areas and 
decreased in others. Post-withdrawal assessments indicated relative elevation 
of cerebral blood flow in inferior temporal regions and reduction in the superior 
temporal regions during alcohol withdrawal (Caspari et al, 1993).  Lyons et al 
(1998) postulated that diminished functional activity in alcohol withdrawal may 
be a function the length of chronic alcohol abuse, while increased activity 
noticed in the withdrawal state may be related to auditory hallucinations and 
agitation.     
Note:  Patients with concurrent alcohol-withdrawal were excluded from the 
study and  some patients had relapsing psychotic features clearly associated 
with alcohol intoxication and/or withdrawal that did not clear upon abstinence 
prior to entering the study.      
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Notwithstanding the clinical differences between alcohol-induced psychotic 
disorder and alcohol withdrawal, the shared increased regional cerebral flow, 
particularly to the temporal lobes, demonstrated in this study, may be 
indicative of mutually shared impaired neuronal mechanisms underlying the 
pathogenesis of these two alcohol-related psychiatric disorders.     
 
No significantly reduced cerebral flow compared to healthy volunteers 
could be demonstrated in any of the areas investigated.  Reduced flow to the 
thalamus as suggested in case reports by Soyka (2000a, 2000b, 2005) and 
Kitabayashi (2007) could thus not be confirmed.  However this is the first 
study of rCBF in groups of subjects.  Given some evidence of increased flow 
to the left thalamus noted in our study, asymmetric rCBF to the thalamus 
remains a plausible explanation for some of their findings.   
 
4.4.2 Regional cerebral blood flow in patients with alcohol-induced 
psychotic disorder vs schizophrenia.   
Psychopathological differences between alcohol-induced psychotic disorder 
and schizophrenia may be reflected by baseline perfusion group differences. 
The significantly higher rCBF found in one cluster of the right mid- 
temporal lobe in patients with alcohol-induced psychotic disorder compared 
to those with schizophrenia is similar to the higher rCBF to the right mid–
temporal lobe detected in our comparison of alcohol-induced psychotic 
disorder patients with healthy volunteers.  Hypoperfusion to the temporal 
lobes in schizophrenia as indicated in previous reports (Crow 1990, Paulman 
 80
et al 1990, Catafau et al 1994, Klemm et al 1996) could also accentuate such 
a comparative finding.   
 
The comparative reduced flow in a small cluster of the the left frontal lobe 
in the alcohol-induced psychotic disorder group is interesting.  It could be 
postulated that it is consistent with decreased rCBF to the frontal lobes 
reported in alcohol dependence (Moselhy et al, 2001).  These results lend 
some support to the view that different neuronal mechanisms are operative in 
alcohol-induced psychotic disorder and schizophrenia.  Differences in 
thalamic and striatal rCBF between patients with alcohol-induced psychotic 
disorder and schizophrenia are amongst the possible abnormalities that could 
not be demonstrated. These findings however, do not exclude the possibility 
of a shared biological substrate in these disorders.       
 
4.4.3 Regional cerebral blood flow in patients with alcohol-induced 
psychotic disorder vs alcohol dependence.    
Although these results suggest some increased rCBF in the parahippocampal 
region of the left temporal lobe in patients with alcohol-induced psychotic 
disorder when compared to patients with alcohol dependence, the majority of 
the differences demonstrate areas with relatively lower flow in patients with 
alcohol-induced psychotic disorder .    
 
Following the generally increased rCBF demonstrated in patients with alcohol-
induced psychotic disorder, when compared to healthy volunteers, the 
expectation may have been to predict similar increased rCBF trends when 
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comparing rCBF in patients with alcohol dependence.  Our findings however 
suggest predominantly reduced relative rCBF to portions of the left frontal 
lobe, the left putamen, and the mid-temporal lobe bilaterally in patients 
with alcohol-induced psychotic disorder.  The role of these areas of reduced 
rCBF in patients with alcohol-induced psychotic disorder remains to be 
determined. The possibility is that it represents areas of more severe 
impairment in patients already known with alcoholism.  
         
The only area that showed relatively increased rCBF is the left 
parahippocampal gyrus. These differences may reflect a possible role of 
this area in the pathogenesis of hallucinations in alcohol-induced psychotic 
disorder.  The left parahipppocampal gyrus is one of the areas reported to be 
associated with hallucinations and increased brain activity in patients with 
schizophrenia (Silbersweig et al, 1995).   
           
4.4.4 Regional cerebral blood flow in patients with alcohol-induced 
psychotic disorder pre- vs post-therapy.   
Areas associated with significantly higher rCBF in patients with alcohol-
induced psychotic disorder in comparison to healthy volunteers could be 
expected to show post-therapy de-activation. Two such areas were 
identified. Two clusters were in the left superior frontal lobe (MNI 
coordinates: -16,36,36 and -20,32,32) associated with increased rCBF vs 
volunteers and with decreased rCBF post vs pre-therapy. Two other clusters 
were in the right mid temporal/ hippocampus region (MNI coordinates: 
36,8,-28, and 40,-4,-20) associated with increased rCBF vs volunteers and 
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with decreased rCBF post vs pre-treatment.  Given the limited spatial 
resolution of SPECT, the coordinates of these two pairs of clusters are close 
enough (<20mm) to represent the same anatomical areas. These findings 
could be interpreted as a post-treatment normalization of activation of 
rCBF in alcohol-induced psychotic disorder. Alternatively, they may reflect 
a general improvement following abstinence from alcohol. This possibility 
however seems less likely, because previous reports suggest that post-
abstinence is associated with increased rCBF, especially to the frontal lobes 
(Ishikawa et al, 1986; Lyons et al 1998; Gansler et al 2000 and Moselhy et al, 
2001).  In addition, these specific clusters did not show increased baseline 
rCBF when compared to the alcohol-dependent group.   (Unfortunately 
however, these areas did not show any positive correlations between change 
in rCBF and improvement on any of the PANSS ratings in the treatment study. 
See next section.)        
 
Further supportive evidence for right mid-temporal involvement comes from 
the fact that other right mid-temporal clusters also showed significant rCBF 
differences when compared to healthy volunteers and schizophrenia 
(increased flow) and alcohol dependence (reduced flow) groups.  
 
The right mid-temporal region has been implicated in the pathogenesis of 
hallucinations in schizophrenia.  Because the temporal cortex is regarded as a 
final destination for the perception of complex speech, it may include auditory 
hallucinations. A number of studies have reported an association between 
activation in the language areas and auditory hallucinations (Woodruff et al, 
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2004).  These include the superior temporal gyri (bilateral) and the right mid- 
temporal region.  Woodruff et al, 1997 (utilizing functional MR Imaging) 
reported that external speech activated the temporal cortex (especially the 
right middle temporal gyrus and the left superior temporal gyrus) less 
extensively in the in the presence than the absence of active auditory 
hallucinations in patients with schizophrenia.  This has been referred to as 
“saturation theory” suggesting that the language related brain regions in 
patients with schizophrenia have less capacity to process normal auditory 
input.  Furthermore, patients with schizophrenia showed less left- sided and 
more right-sided auditory cortical responses to external speech than healthy 
volunteers (reversed laterality). This could be interpreted as primary hyper-
responsivity of the right temporal cortex and/or a compensatory increase due 
to dysfunction of the left temporal cortex (Woodruff, 2004). This illustrates how 
increased/reversed activity (in comparison with healthy volunteers) in one 
brain hemisphere may be associated with impaired function not only of that 
particular region, but also with regard to the opposite hemisphere.   Although 
this lillustration is applicable to schizophrenia, it is possible that similar 
neurocircuitry in the right mid-temporal region may be involved in the 
pathogenesis of auditory hallucinations in alcohol-induced psychotic 
disorder.               
 
As there were no areas demonstrated with significantly lower rCBF in patients 
with alcohol-psychotic disorder in comparison to healthy volunteers, post 
therapy activation may be less likely.  Post-therapy activation (predominantly 
in the left frontal lobe) is however consistent with differences in rCBF shown in 
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comparison to the schizophrenia and alcohol dependent groups.  Given the 
fact that chronic alcohol intake is associated with decreased frontal lobe 
perfusion (Moselhy et al, 2001), the post-treatment increased perfusion 
demonstrated here may be consistent with post-abstinence 
improvement (Gansler et al, 2000) and perhaps less likely a definite 
treatment effect.  One particular area that could support this was found in the 
left basal ganglia. The cluster in the left putamen (MNI coordinates: -20,16,-4) 
had decreased rCBF compared  to the alcohol dependence group. A cluster in 
the left caudate (MNI coordinates: -12,16,12) reported with increased post-
treatment rCBF, share coordinates that may represent the same anatomical 
area. “Baseline-deactivation” was thus followed by post-treatment 
“normalisation”.  The possibility however also remains that anti-psychotic 
treatment exerting its dopamine-blocking effect in the basal ganglia 
contributed to this finding.  Increased metabolic rates in the basal ganglia 
have been reported in response to treatment with haloperidol in patients with 
schizophrenia.  A study by Buchsbaum et al (1992) demonstrated an 
association with clinical response, but another by Miller et al (1997) was 
unable to do so.                         
 
4.5  Conclusion of SPECT study 
Baseline activation of rCBF of certain brain regions (including the superior 
medial aspect of the right frontal lobe, left pre-central frontal lobe, right 
pallidum and mid-region of right temporal lobe) distinguished this disorder 
from healthy volunteers.  Reduced rCBF to the thalamus as suggested in 
previous case reports (Soyka et al, 2000a, 2000b, 2005 and Kitabayashi et al 
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2007) could not be confirmed.  Increased rCBF to the left thalamus may 
explain previously reported asymmetric flow to the thalamus (Soyka et al 
2005).  
 
Only two significant and heterogeneous rCBF differences were demonstrated 
when comparing patients with alcohol-induced psychotic disorder with 
patients with schizophrenia, involving the left frontal and right mid-temporal 
lobes.  
 
Heterogenous rCBF in alcohol-induced psychotic disorder was also evident 
but less prominent in comparison with alcohol dependence.  The predominant 
finding was reduced comparative rCBF to portions of the left frontal lobe, the 
basal ganglia and the mid-temporal lobe bilaterally.      
 
Areas that showed significant baseline activation and post-treatment de-
activation and are likely to be involved in the pathogenesis of alcohol-induced 
psychotic disorder are the left superior frontal lobe and the right mid-
temporal/hippocampus region.  
 
As both post-treatment de-activation and activation were noted, it is 
postulated that areas associated with increased pre-treatment rCBF and post-
treatment de-activation may reflect improvement more closely related to 
alcohol-induced psychotic disorder, whilst areas of post-treatment activation 
may be associated with a post-abstinence improvement effect.      
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4.6 Combined SPECT and Psychopathology (PANSS) study – Pre and 
Post Treatment correlations in Alcohol Induced Psychotic Disorder: 
Results  
 
4.6.1  Demographics    
The nineteen (n=19) participants (15 male, 4 female) with a mean (SD) age of 
39 (4) years with alcohol-induced psychotic disorder that participated in the 
comparative baseline SPECT study were included and completed the 6-week 
treatment component of this study.     
 
4.6.2  SPECT vs PANSS correlation results 
 
4.6.2.1  Baseline correlations of rCBF and PANSS ratings in patients 
with Alcohol-induced Psychotic Disorder when assessing all brain 
areas.   
The only significant positive correlation detected between rCBF and the 
PANSS at baseline was between the Positive scale of the PANSS and rCBF 
in the right cerebellum (table 15).  Negative correlations were noted between 
the Negative, General and Total PANSS scales and rCBF in the right frontal 
lobe, the right occipital (fusiform) lobe, the right parietal lobe and the vermis of 
the cerebellum.  Noticeably no correlations were detected in the left 
hemisphere of the brain. These results are summarised in tables 16-18.              
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Table 15.  Positive correlation between rCBF and Positive PANSS at 
baseline  
Cluster size 
(voxels) 
T p value MNI coordinates 
(x,y,z) 
Brain region 
15 4.78 p<0.001 8,-80,16 Cerebellum  R 
(Height threshold: T=3.65, p=0.001)  
 
Table 16. Negative correlation between rCBF and Negative PANSS at 
baseline) 
Cluster size 
(voxels) 
T p value MNI coordinates 
(x,y,z) 
Brain region 
11 4.8 p<0.001 40,-8,20 Rolandic Operculum R
13 4.45 p<0.001 20,-40,-12 Occipital Fusiform R 
15 4.2 p<0.001 16,20,52 Frontal Sup R  
(Height threshold: T=3.65, p=0.001)  
 
Table 17.  Negative correlation between rCBF and General PANSS at 
baseline.  
 
Cluster size 
(voxels) 
T p value MNI coordinates 
(x,y,z) 
Brain region 
13 4.72 p<0.001 40,-36,40 Supramarginal R 
22 4.4 p<0.001 0,-40,-20 Cerebellum Vermis  
(Height threshold: T=3.65, p=0.001)  
  
Table 18. Negative correlation between rCBF and Total PANSS at 
baseline 
Cluster size 
(voxels) 
T p value MNI coordinates 
(x,y,z) 
Brain region 
21 4.86 p<0.001 12,20,48 Supplementary Motor 
Area R 
(Height threshold: T=3.65, p=0.001)  
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4.6.2.2  Correlations of changes in rCBF and changes in PANSS ratings 
post vs pre treatment in patients with Alcohol-induced Psychotic 
Disorder when assessing all brain areas.   
No significant correlations were detected between changes in rCBF and 
ratings on the Positive scale of the PANSS following pharmacotherapy.   
 
Highly significant negative correlations were detected between changes 
in rCBF and changes on the Negative subscale of the PANSS following 
pharmacotherapy.  These rCBF changes were predominantly in the left frontal 
lobe (6 clusters), the right frontal lobe (2 clusters), the parietal lobes, including 
the supramarginal regions bilaterally (3 clusters), the left temporal lobe, the 
left occipital lobe and the left cerebellum.  (See table 19).             
Table 19.  Negative correlation between changes in rCBF and Negative 
PANSS following pharmacotherapy (activation).  
Cluster size 
(voxels) 
T p value MNI coordinates 
(x,y,z) 
Brain region 
33 5.89 p<0.001 -32,52,12 Frontal Mid L 
51 5.64 p<0.001 36,16,32 Frontal Inf Operculum 
R  
88 5.49 p<0.001 -28,-12,68 Frontal Pre Central L 
94 5.32 p<0.001 -52,16,24 Frontal Inf Operculum 
L 
50 5.28 p<0.001 32,44,20 Frontal Mid R 
22 5.27 p<0.001 -56,-20,24 Parietal Supra 
Marginal L  
72 4.9 p<0.001 -12,12,64 Supplementary Motor 
Area L  
16 4.88 p<0.001 -8,48,28 Frontal Superior 
Medial L 
10 4.87 p<0.001 -48,-20-24 Temporal Inferior L  
43 4.68 p<0.001 44,-40,44 Parietal Supra 
Marginal R 
16 4.66 p<0.001 -12,-60,-40 Cerebellum  L  
27 4.61 p<0.001 -28,-48,56 Parietal Inferior L  
16 4.53 p<0.001 -20,-96,12 Occipital Mid L  
10 4.0 p<0.001 -8,-24,36 Cingulum Mid L 
(Height threshold: T=3.65, p=0.001)  
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Further negative correlations were evident when comparing changes in rCBF 
and changes on the General subscale of the PANSS.  Significant changes 
correlated with bilateral changes in rCBF in the temporal lobes (2 clusters 
each), the right frontal region (4 clusters), the left cerebellum, left 
thalamus and the right parietal lobe (precuneus) (one cluster each). (See 
table 20.)         
 
Table 20.  Negative correlations between changes in rCBF and General 
PANSS following pharmacotherapy (activation).  
Cluster size 
(voxels) 
T p value MNI coordinates 
(x,y,z) 
Brain region 
61 6.32 p<0.001 -48,-16,4 Temporal Sup L  
33 5.79 p<0.001 -12,-56,-40 Cerebellum L 
16 5.51 p<0.001 -52,-20,-24 Temporal Inf L 
43 5.5 p<0.001 -8,-20,20 Thalamus L  
144 4.94 p<0.001 28,16,48 Frontal Mid R  
22 4.89 p<0.001 28,-24,-8 Hippocampus R 
35 4.87 p<0.001 44,-8,-28 Temporal Inf R 
40 4.66 p<0.001 28,44,24 Frontal Mid R  
29 4.66 p<0.001 12,-56,56 Parietal Precuneus R 
10 4.63 p<0.001 4,-20,60 Supplementary Motor 
area R 
12 4.62 p<0.001 52,-12,12 Rolandic Operculum R 
(Height threshold: T=3.65, p=0.001)  
 
The brain regions associated with significant negative correlations between 
changes in rCBF and changes on the Total PANSS ratings were the 
temporal lobes (one cluster each bilaterally), the right frontal lobe (2 
clusters) and the left parietal lobe and left cerebelum with one cluster 
each. (See table 21.)       
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Table 21. Negative correlations between changes in rCBF and Total 
PANSS following pharmacotherapy (activation).   
Cluster size 
(voxels) 
T p value MNI coordinates 
(x,y,z) 
Brain region 
19 6.66 p<0.001 -52,-20,-24 Temporal Inf L 
47 5.81 p<0.001 -56,-20,20 Parital Supramarginal 
L 
63 5.29 p<0.001 36,12,28 Frontal Inf Operculum 
R  
20 5.26 p<0.001 28,-24,-4 Hippocampus R 
14 4.63 p<0.001 -12,-60,-44 Cerebellum  L  
10 4.02 p<0.001 28,44,20 Frontal Mid R 
(Height threshold: T=3.65, p=0.001)  
 
We failed to demonstrate any significant positive correlations between 
changes in rCBF and improvement on any of the PANSS rating scales.                     
 
4.7  Discussion of  SPECT vs  PANSS correlations   
Significant correlations with change in rCBF and change on the various scales 
of the PANNS implicate involvement of the frontal, temporal, parietal and 
occipital lobes as well the cerebellum and the left thalamus in alcohol-induced 
psychotic disorder.  No significant correlations were demonstrated between 
rCBF to the basal ganglia and any of the PANSS ratings.         
 
4.7.1  Baseline correlations of Regional Cerebral Blood Flow (rCBF) and   
PANSS ratings in patients with Alcohol-induced Psychotic Disorder 
when assessing all brain areas.   
In view of prominent individual item and total scores on the Positive subscale 
of the PANSS (see table 7) and significant baseline rCBF differences between 
patients with alcohol-induced psychotic disorder and healthy volunteers,  
significant baseline correlations were anticipated between these two 
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variables.  Only one significant correlation (positive) between baseline 
rCBF and the Positive subscale of the PANSS could however be 
detected, specifically in a portion of the right cerebellum. Interesting is 
that another cluster of the cerebellum (the vermis) showed a significant 
inverse correlation between baseline rCBF and the General subscale of 
the PANSS. The explanation for these correlations is unclear.  However, the 
cerebellum has been implicated in the pathogenesis of Wernicke’s 
encephalopathy (cerebellar ataxia, opthalmoplegia and delirium) due to 
thiamine deficiency.  Baker et al (1999) reported that thiamine-deficient 
patients with alcoholism had cerebellar changes that differed significantly from 
non-thiamine-deficient alcoholic patients.  Thiamine-deficient alcoholic 
patients had significant decreases in Purkinje cell density and molecular layer 
volume in the cerebellar vermis suggesting selective vulnerability to thiamine 
deficiency in the cerebellum.   Thiamine deficiency in alcoholic patients is also 
associated with reduced white matter volumes especially of the frontal and 
medial temporal lobes, but also of the thalamus (Krill et al 1997). Thiamine 
deficiency has thus far not been directly implicated in the develpment of 
alcohol-induced psychotic disorder but its potential role remains to be 
elucidated. 
 
The role of the cerebellum has traditionally mainly been associated with motor 
coordination.  It has however been shown that the cerebellum is also involved 
in neurocircuitry with links to pre-frontal, temporal and occipito-parietal 
association areas as well as the limbic system.  Activation of the cerebellum 
has been demonstrated during cognitive tasks not related to movement as 
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reviewed by Bugalho et al 2006 and reduced cerebellar blood flow was 
associated with cognitive dysfunction in patients with chronic alcoholism 
(Melgaard et al 1990). Several authors have proposed a possible modulating 
role for the cerebellum in cognitive control (Rapoport et al 2000, Konarski et 
al, 2005, Bugalho et al, 2006 and Fusar-Poli et al, 2007), including a possible 
role in the pathogenesis of psychiatric disorders such as schizophrenia 
(Andersen, 2003).  A possible role for the cerebellum in alcohol-induced 
psychotic disorder therefore warrants further investigation.                                      
 
None of the sites associated with significant negative correlations between 
baseline rCBF and the Negative, General and Total subscales of the PANNS 
were followed by significant post-treatment correlations at that specific site.  
Significant correlations between baseline rCBF and the Negative subscale of 
the PANSS involving the right frontal lobe supports frontal lobe involvement 
in alcohol induced-psychotic disorder as discussed elsewhere in this paper.           
 
4.7.2  Correlations of changes in Regional Cerebral Blood Flow (rCBF) 
and changes in PANSS ratings post vs pre treatment in patients with 
Alcohol-induced Psychotic Disorder when assessing all brain areas.   
Hallucinations clinically constitute a prominent symptom in alcohol-induced-
psychosis and are represented by item p3 in the Positive subscale of the 
PANSS.  Although hallucinations were prominent in the cohort of patients with 
alcohol-induced psychotic disorder and significant symptom reductions were 
noted on both the p3 and Positive subscale of the PANSS, we failed to 
demonstrate significant correlations between change in rCBF and 
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improvement on the Positive subscale of the PANSS.  Sabri et al (1997) 
encountered similar findings in a study involving never-treated patients with 
schizophrenia.  Areas of hyperperfusion and hypoperfusion correllated 
exclusively with different positive symptoms, while the sumscore of of all the 
positive symptoms only correlated weakly with rCBF changes. This provides a 
possible explanation for failure to detect an equally strong correlation between 
changes in rCBF and changes on the positive PANSS subscale.  It was 
suggested that different positive symptoms may produce opposite rCBF 
changes, thus cancelling out deviations. Individual symptom score 
correlations were not performed in this study, so that this possibility could not 
be further explored.         
 
The absence of significant correlations between change in rCBF to the basal 
ganglia and any of the PANNS ratings is noteworthy.  Anti-psychotic agents 
such as haloperidol exert its effects via meso-limbic, meso-cortical and nigro-
striatal pathways.  Any potential nigro-striatal therapeutic effects as measured 
by PANNS ratings and involving the basal ganglia may thus be interpreted as 
negligent or absent.  This however also does not rule out possible individual 
symptom score correlations on the Positive subscale of the PANSS.            
     
Improvement on the Negative subscale of the PANSS showed a number 
of highly significant negative correlations with change in rCBF post vs 
pre-therapy in patients with alcohol-induced psychotic disorder.  The 
clusters involved were predominantly localized in the frontal lobes; six from 
the left and two from the right frontal lobe (see table 19).  These findings were 
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unexpected in view of the fact that negative symptoms do not represent the 
core features of alcohol-induced psychotic disorder.  Also, baseline negative 
symptom scores were low in our sample. Furthermore, we did not find 
statistical significant improvement on the Negative subscale of the PANSS 
when assessing psychopathology independently from change in rCBF (see 
psychopathology section).  Nevertheless, we found individual items on the 
Negative subscale that demonstrated significant improvement after treatment.  
These were the items representing emotional withdrawal (item n2), 
passive/apathetic social withdrawal (item n4) and stereotyped thinking (item   
n7).  
 
These improvements are unlikely due to anti-psychotic treatment alone. It is 
quite plausible to consider that these correlations may also represent a post-
treatment abstinence improvement effect given the fact that frontal brain 
perfusion abnormalities may subside with extended abstinence (Gansler et al, 
2000).  As the changes on the Negative subscale of the PANSS were score 
reductions (improvement), these negative correlations with change of rCBF 
are likely to reflect post-therapy increase of rCBF. 
     
Rosse et al (1997) found a significant relationship between frontal lobe 
pathology as measured by CT and negative symptoms measured by the 
Negative Scale of the PANSS in patients with chronic alcoholism. We noted 
three regions of the left frontal lobe that showed both significant increased 
rCBF post vs pre therapy and change of rCBF that correlated significantly 
negatively with change (improvement) on the Negative subscale of the 
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PANSS.  These areas were the left supplementary motor area (MNI 
coordinates: -8,0,68 and -12,12,64), the left pre-central region (MNI 
coordinates: -24,-24,64 and -28,-12,68) and the mid cingulum (MNI 
coordinates: 0,-12,40 and -8,-24,36).  Each set of two MNI coordinates 
represent a cluster close enough to represent one anatomical area (< 20mm 
apart).  Noticeably no other brain region demonstrated this combination of 
findings.  Though it was difficult to verify, most of our patients reported 
abstinence during the study.   
 
We therefore postulate that these frontal lobe rCBF changes correlating 
significantly negatively with changes on the Negative subscale of the 
PANSS may represent improvement subsequent to extended abstinence 
from alcohol.   
 
Of particular interest are two anatomical areas in the left frontal lobe each 
represented by two clusters, less than 20mm apart, that displayed both 
significant  increased baseline rCBF vs volunteers (as reported in the previous 
section) and change of rCBF post vs pre therapy correlating significantly 
negatively with change on the Negative subscale of the PANSS.  These areas 
were located in the left mid frontal lobe (MNI coordinates: -24,48,8 and -
32,52,12) and an area associated with the deep central region and inferior 
operculum of the left frontal lobe (MNI coordinates:-44,0,24 and -52,16,24).   
We previously reported two other areas that were associated with significant 
increased baseline rCBF vs volunteers and post-therapy de-activation. This 
finding indicates that increased baseline rCBF vs volunteers may also be 
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associated with change of rCBF post vs pre therapy correlating significantly 
negatively with change on the Negative subscale of the PANSS in specific 
anatomical areas.   
        
A possible explanation is that baseline rCBF activation could be followed by 
post-treatment rCBF activation in some areas, as both post-treatment 
activation and de-activation were demonstrated in the previous section. 
Evidence also points to post-treatment activation as a rCBF feature 
associated with clinical improvement.  This is supported by significant 
negative correlations between improvement on the Negative, General and 
Total PANSS scores and the absence of any positive correlations between 
improvement on any of the PANSS rating scales and change of rCBF.  It is 
further postulated that some areas of activation may represent compensatory 
mechanisms for areas of de-activation elsewhere. This is also consistent with 
the possibility that post-treatment activation represents post-abstinence 
improvement as suggested earlier.             
 
Three anatomical areas demonstrated significant negative correlations 
between changes of rCBF and simultaneous improvement on the Negative,  
General  and  Total PANSS scores.  (Note that the Negative and General 
scores are included in the Total PANSS score).  The three areas were located 
in the right mid frontal lobe (MNI coordinates: 28,44,24 and 28,44,20 and 
32,44,20), the left inferior temporal lobe (MNI coordinates: -48,-20,-24 and -
52,-20,-24 and -52-20,-24)  and the left cerebellum (MNI coordinates: -12,-
60,-44 and -12,-60,-40 and -12,-56,-40).  Each of these three areas were 
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represented by 3 sets of coordinates that represented clusters that were less 
than 20mm apart.  A likely interpretation is that the Negative and General 
subscales of the PANSS share related items/symptoms that are 
simultaneously operative in the improvement of alcohol-induced psychotic 
disorder at these locations.  Similarly, it also supports the notion that these 
structures are involved in the pathogenesis of alcohol-induced psychotic 
disorder.     
  
Given the pharmacodynamic action of haloperidol exerting its therapeutic 
action on D2 receptors in mesocortical and mesolimbic pathways involving the 
frontal and temporal lobes, we postulate that changes in rCBF involving these 
structures and that correlate with clinical improvement, may also reflect a 
pharmacological treatment effect.                               
 
Assessment of parietal lobe rCBF was not included in the comparative  
SPECT study.  Change of rCBF to the parietal lobes however showed 
significant negative correlations with improvement on the various scales in the 
treatment study.  These included rCBF changes to the right precuneus region 
and bilateral supramarginal regions of the parietal lobes.  Change of rCBF to 
the left supramarginal area was represented by two almost identical clusters 
that showed significant negative correlations with improvement on both the 
Negative and the Total PANSS scores.  A lesion affecting the supramarginal 
area is usually associated with hemi-neglect.  The left tempero-parietal cortex 
(including the supramarginal region) is however also involved in phonological 
retrieval and a deficit may be associated with interference with “inner speech” 
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(Shergill et al 2001). Our findings suggest that it may play a role in alcohol-
induced psychotic disorder, especially if one considers a possible association 
with symptoms such as auditory hallucinations.  Noteworthy is that diminished 
regional cerebral glucose utilization in the left parietal lobe (Martin et al, 1992) 
and precuneus (Joyce et al, 1994) have been reported in patients with 
alcoholism and Wernicke-Korsakoff’s syndrome respectively.        
 
The negative correlation detected between change in rCBF in the left 
thalamus and improvement on the General PANSS is consistent with previous 
reported impairment of thalamic function in alcohol induced-psychotic 
disorder.  Our findings suggest that left thalamic involvement may explain the 
asymmetric thalamic metabolism reported by Soyka et al 2005.             
 
One site in the  right occipital lobe showed a significant inverse correlation 
between baseline rCBF and the Negative subscale of the PANSS.  Another 
site in the left occipiatal lobe showed a significant correlation between change 
of rCBF and improvement on the Negative subscale of the PANSS.  The 
possibility is that this reflects a relative post-therapy increase of rCBF to left 
occipital lobe.  Occipital lobe dysfunction in this disorder may explain the 
occasional occurrence of visual hallucinations in alcohol-induced psychotic 
disorder.   
 
4.8  Conclusion of Treatment Study  
Significant negative correlations between change in rCBF and improvement 
on Negative, General and Total PANSS ratings,  support our earlier finding 
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which implicate dysfunction of the the frontal and temporal lobes as well as 
the thalamus in alcohol-induced psychotic disorder.  Further evidence also 
points towards involvement of the parietal and occipital lobes and the 
cerebellum.  Basal ganglia involvement could not be confirmed in this 
component of the study.  The lack of significant correlations between change 
in rCBF and the Positive subscale of the PANSS may not reflect possible 
correlations between rCBF and individual items of the Positive subscale.  
 
Although treatment effects were demonstrated, we were unable to distinguish 
between pharmacological effects and the possible improvement accomplished 
by abstinence from alcohol. However, a treatment effect is suggested by the 
fact that the majority of patients previously had relapsing psychotic features 
clearly associated with alcohol intoxication and/or withdrawal that did not clear 
upon abstinence prior to entering the treatment study.  We postulate that both 
mechanisms  could be simultaneously operative.   
 
Negative correlations between rCBF changes and change on the various 
PANSS scales point to post-treatment activation as a rCBF feature associated 
with clinical improvement.           
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5.  FINAL CONCLUSIONS 
This study provides further supportive evidence for the view that alcohol-
induced psychotic disorder can be distinguished from schizophrenia.  Our 
findings confirmed that the age of onset of alcohol-induced psychotic 
disorder is higher than that of schizophrenia (Soyka, 1990).  Evidence from 
our cohort also points to a lower pre-morbid educational level in the 
alcohol-induced psychotic disorder group.  Along with the mild cognitive 
impairment detected in comparison with healthy volunteers and alcohol 
dependent patients, it may be indicative of a possible developmental risk 
factor.     
 
We were unable to confirm a greater degree of alcohol dependence in this 
disorder.  As concomitant substance abuse was an exclusion criterion in this 
study, we are of the opinion that other substance abuse is not an essential 
risk factor for the development of this disorder.                
 
Co-morbid anxiety and depressive symptoms were noted significantly 
more in the alcohol-induced psychotic disorder group compared to the 
schizophrenia group.  Our findings suggest that these symptoms represent 
features of alcohol-induced psychotic disorder rather than independent 
anxiety or depressive disorders.  Whether the high rate of suicidal behaviour 
reported by patients with alcohol-induced psychotic disorder (35.7%) and 
noted in other studies (Soyka et al, 1988) is a reflection of anxiety, depression 
or psychosis or a combination there of, remains to be determined.          
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Patients with alcohol-induced psychotic disorder presented with significantly 
less severe psychotic features, better jugdement, insight and awareness 
of their condition and less functional impairment than patients with 
schizophrenia.  In addition, we found virtualy no evidence of thought process 
disorder in our cohort of patients with alcohol-induced psychotic disorder.  
Negative symptoms as measured by the negative scale of the PANSS and 
generally associated with a negative symptom syndrome in schizophrenia, 
were significantly milder in the alcohol-induced psychotic disorder patients 
compared to the schizophrenia group.  Notwithstanding these low ratings and 
lack of significant improvement noted on the negative scale of the PANSS 
post-therapy, improvement of these symptoms correlated significantly with 
change in rCBF to predominantly the frontal lobes in patients with alcohol-
induced psychotic disorder.  The explanation of these findings is not clear.  
Looking at the post-therapy improvement of individual items on the negative 
scale of the PANSS, we found that three items (item 2, emotional withdrawal; 
item 4, passive social withdrawal and item 7, stereotyped thinking) showed 
significant post-therapy improvement whilst four items (item 1, blunted affect; 
item 3, poor rapport; item 5, poor abstract thinking and item 7, stereotyped 
thinking) did not show significant improvement.  It remains possible that 
improvement of the three individual symptom items were responsible for the 
correlation with significant changes noted in rCBF post therapy.  Taking in 
account that these individual items do not include psychotic symptoms of 
alcohol-induced psychotic disorder, we would argue that it is more likely that 
these symptoms did not improve due to anti-psychotic treatment (alone) but 
rather improved due to abstinence from alcohol.  It is further postulated that a 
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lack of significant improvement on the negative scale of the PANSS may be 
indicative of relatively chronic symptoms associated with alcoholism.   
 
The significant improvement noted on the positive, general and total scales of 
the PANSS is consistent with previous reports (Johannson, 1961; Glass, 1989 
and Soyka, 1990) indicating reversibility and good prognosis of alcohol-
induced psychotic disorder providing abstinence is maintained.        
 
Significant differences in baseline rCBF between patients with alcohol-
induced psychotic disorder and patients with schizophrenia were also 
demonstrated in the baseline SPECT study.  Higher and lower rCBF in 
patients with alcohol-induced psychotic disorder were noted to the right mid 
temporal and left frontal lobes respectively.  We indicated that the likelihood 
exists that the right mid-temporal region be similarly involved in the 
pathogenesis of auditory hallucinations in alcohol-induced psychotic disorder 
as in schizophrenia. No significant differences could however be 
demonstrated between baseline thalamic and striatal rCBF of these two 
patient groups.  Our findings do not exclude some possible shared biological 
substrate between these disorders.   
           
Significantly higher baseline rCBF to especially the medial aspect of the right 
and pre-central aspect of the left frontal lobes, but also to the right pallidum,  
mid-region of the right temporal lobe and left thalamus distinguished this 
disorder from healthy volunteers.  Although the asymmetrical rCBF noted to 
the thalamus was consistent with previous reports, reduced rCBF to the 
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thalamus could not be confirmed. Increased rCBF to certain portions of the   
temporal cortex in patients with alcohol-induced psychotic disorder and 
previously reported in patients with alcohol-withdrawal, may point towards 
mutually impaired neuronal mechanisms contributing to the pathogenesis of 
the two alcohol-related disorders.              
 
Heterogeneous rCBF was also noted in the alcohol-induced psychotic 
disorder group in comparison with alcohol dependent patients, the 
predominant findings being reduced comparative rCBF to portions of the left 
frontal lobe, the basal ganglia and the mid-temporal lobe bilaterally.            
  
Both post-treatment de-activation and activation were noted. We 
postulate that areas associated with increased pre-treatment rCBF and post-
treatment de-activation (eg. the left superior frontal lobe and right mid-
temporal /hippocampus region) reflect improvement of alcohol-induced 
psychotic disorder, whilst areas of post-treatment activation (eg. left 
supplementary motor area, left caudate and left Rolandic operculum) may 
reflect an improvement due to abstinence from alcohol.   
 
Significant positive and inverse correlations between the positive and general 
subscales of the PANSS respectively and rCBF to cerebellar regions, 
implicate the cerebellum and possibly thiamine deficiency as having 
possible roles in the pathogenesis of alcohol-induced psychotic disorder.   
These findings warrant further investigation.    
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Whilst we failed to demonstrate significant correlations between change in 
rCBF and improvement on the positive subscale of the PANSS, we suggest 
that individual positive subscale item symptoms may produce opposite rCBF 
changes, thus possibly cancelling out deviations.  Assessment of individual 
item correlations with rCBF changes did not fall into the scope of this study, 
but further exploration of these data is envisaged.  Changes in the basal 
ganglia could not be associated with a significant improvement effect. We 
believe that this may be due to the same methodological discrepancy.            
 
Evidence indicating that changes in specific frontal, temporal, parietal, 
occipital, thalamic and cerebellar rCBF showed significant negative 
correlations with improvement on the negative, general and total PANSS 
ratings, implies dysfunction of these areas in alcohol-induced psychotic 
disorder.  Although treatment effects were demonstrated, we were unable to 
distinguish between pharmacological effects and the possible improvement 
accomplished by abstinence from alcohol. We postulate that both 
mechanisms are simultaneously operative.   
 
Although demonstration of possible dysfunctional anatomical brain regions 
may imply the existence of focal brain abnormalities, evidence point towards a 
“dysfunctional network” in alcohol-induced psychotic disorder rather than a 
“single aberrant centre”, as also postulated in schizophrenia  (Shergill, 
Cameron et al 2001; David, 2004, Stephan et al 2006).            
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5.1  Limitations and future directions 
Interpretation of some results may have limitations due to small sample sizes 
and disproportion of gender.  In the SPECT studies there were disproportions 
of women in the schizophrenia (higher) and in the alcohol dependent (lower) 
groups compared to the alcohol-induced psychotic disorder group 
respectively.  A certain amount of selection bias may have preceded the study 
in view of the exclusion of disorders (eg. comorbid mood and anxiety 
disorders) that may arguably contribute to the pathogenesis of the disorder.    
Though our patients did not suffer from primary mood and or anxiety 
disorders, future studies may need to uitilize a control design to assess the 
potential role of such disorders.  
 
Although serious efforts were made to exclude substance related disorders, 
negative screening could not rule out subsequent use during the course of the 
study.  Cigarette smoking (which was not disallowed) during the study in 
combination with alcohol use disorders may also affect brain perfusion 
particularly to the frontal lobes (Durazzo et al, 2007).  Similar efforts were 
made to exclude comorbid general medical disorders.  HIV-serology and EEG 
assessments were however not performed.  The treatment arm of this study 
lacked a double-blind controlled study design. It was difficult to guarantee 
sobriety amongst patients after initiation of the study, thus possibly 
confounding treatment effects.  Future studies may therefore need to address 
these factors.        
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Nevertheless, the results of this study are encouraging, particularly because 
to our knowledge, this is one of the few prospective studies and the first 
documented neuro-imaging study in alcohol-induced psychotic disorder. 
Previous neuro-imaging reports were based on case reports. Specific 
emphasis is made of the prospective design of this study that utilized 
standardized ratings scales, MRI brain scanning and drug screening 
procedures to allow for amongst others exclusion of comorbid neuro-
psychiatric conditions and substance abuse.  
 
The role of other brain regions such as the parietal lobes and cerebellum as 
well as possible etiological factors such as thiamine deficiency warrant further 
research. Placebo-controlled research specifically designed to distinguish 
between the effect of medication vs the role of abstinence from alcohol would 
be worth exploring.   SPECT studies are generally unable to distinguish 
between changes in rCBF due to atrophy and other causes. Cerebral atrophy 
may thus have inluenced SPECT findings.  Research correlating functional 
and  structural  neuroimaging  would  therefore also be worth exploring. 
   
While there is little evidence that dopamine receptor dysfunction contributes to 
this disorder, the role of dopamine transporter may yet provide additional 
information to the current SPECT findings.  (Soyka et al, 2000a).      
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Appendix A 
 
Substance (alcohol)-induced Psychotic Disorder (DSM IV-TR, 2000): 
 
A.  Prominent hallucinations or delusions.  Note. Do not include hallucinations 
if the person has insight that they are substance induced. 
 
B.  There is evidence from the history, physical examination, or laboratory 
findings of either (1) or (2) : 
 
(1) the symptoms in Criterion A developed during, or within a month of 
substance intoxication or withdrawal  
 
(2)  medication use is etiologically related to the disturbance 
 
C. The disturbance is not better accounted for by a psychotic disorder that is 
not substance induced.  Evidence that the symptoms are better accounted for 
by a psychotic disorder that is not substance induced might include the 
following: the symptoms precede the onset of substance use (or medication 
use); the symptoms persist for a substantial period of time (e.g., about a 
month) after the cessation of acute withdrawal or severe intoxication, or are 
substantially in excess of what would be expected given the amount of the 
substance used or the duration of use; or there is other evidence that 
suggests the existence of an independent non-substance-induced psychotic 
disorder (e.g., a history of recurrent non-substance-related episodes).  
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D.  The disorder does not occur exclusively during the course of a delirium.  
 
Note: This diagnosis should be made instead of a diagnosis of substance 
intoxication or substance withdrawal only when the symptoms are in excess of 
those usually associated with the intoxication or withdrawal syndrome and 
when the symptoms are sufficiently severe to warrant independent clinical 
attention.     
 
Code: [ Specific Substance ] – Induced Psychotic Disorder: 
(Alcohol-Induced Psychotic Disorder with Delusions; Alcohol-Induced 
Psychotic Disorder  with Hallucinations.)  
 
Specify if: 
With onset during intoxication: if criteria are met for intoxication with the 
substance and the symptoms develop during the intoxication syndrome.  
With onset during withdrawal: if criteria are met for withdrawal from the 
substance and the symptoms develop during, or shortly after, a withdrawal 
syndrome.  
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Appendix B 
Psychotic Disorder due to the use of Alcohol (ICD-10, 1993) 
A. Onset of psychotic symptoms must occur during or within 2 weeks of 
substance use. 
B.  The psychotic symptoms must persist for for more than 48 hours. 
C.  Duration of the disorder must not exceed 6 months.  
The diagnosis of psychotic disorder may be further specified by using the 
following: 
Schizophrenia-like  
Predominantly delusional 
Predominantly hallucinatory 
Predominantly polymorphic 
Predominantly depressive symptoms 
Predominantly manic symptoms 
Mixed 
For research purposes it is recommended that change of the disorder from a 
non-psychotic to a clearly psychotic state be further specified as either abrupt 
(onset within 48 hours) or acute (onset in more than 48 hours but les than 2 
weeks).       
   
Late-onset Psychotic Disorder due to Alcohol use (ICD-10) 
A.  Conditions and disorders meeting the criteria for the individual syndrome  
should be clearly related to the substance use.  Where the onset of the 
condition or disorder occurs subsequent to use of psychoactive substances, 
strong evidence should be provided to demonstrate a link.  
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B.   The general criteria for psychotic disorder must be met, except with 
regard to the onset of the disorder,  which is more than 2 weeks but not more 
than 6 weeks after substance use.         
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Appendix C 
 ALKOHOL–GEïNDUSEERDE PSIGOSE STUDIE  
 PASIëNTINLIGTINGSTUK EN TOESTEMMINGSVORM 
 
Hierdie inligtingstuk is saamgestel om dit vir u moontlik te maak om vrylik te 
besluit of u aan hierdie studie wil deelneem.  Lees asb. sorgvuldig. 
 
Wat is die doel van die studie? 
U word gevra om vrywillig deel te neem aan ‘n studie wat breinfunksie in 3 
verskillende toestande (alkoholgeïnduseerde psigose, alkoholafhanklikheid 
en skisofrenie)  met normale kontrole gevalle vergelyk.  
Indien u ly aan alkohol-geïnduseerde psigose sal u ook gevra word om deel 
te neem aan ‘n 6 weke behandelingstudie met toepaslike medikasie vir u 
toestand. Tydens hierdie tydperk sal van u verwag word om nie ander 
medikasie, alkohol of substanse te neem nie. 
Wat word van my verwag tydens die studie? 
As u deelneem aan die studie sal die dokter u bloeddruk,  pols en gewig meet 
en fisies ondersoek. Hy sal u vra om vrae tydens die afneem van ‘n 
gestruktureerde psigiatriese onderhoud te beantwoord. U sal ook gevra word 
om bloed (omtrent 5-10ml of 2-4 teelepels) en uriene monsters te verskaf vir 
toksikologiese sifting. Daar sal gereël word dat u ‘n breinbeeldingstoets 
(SPECT)  en  'n magnetiese resonansie (MR) studie van die brein ondergaan.  
Indien u diagnose alkoholgeïnduseerde psigose is, sal u gevra word om u 
medikasie gereeld te neem en 2 verdere afsprake tydens (na 3 weke) en aan 
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die einde van die studie (na 6 weke) na te kom.  Na afloop van die studie sal 
u weer  dieselfde toetse (behalwe die MR studie) ondergaan.   
  
Wat behels die psigiatriese onderhoud? 
Die ondersoeker sal vrae aan u stel volgens vasgestelde psigiatriese 
vraelyste.  Dit behels gewoonlik soortgelyke vrae as wat u reeds by u eie 
psigiater beantwoord het. 
  
Wat behels die SPECT studie? 
Die SPECT studie behels 'n beelding studie van die brein. Dit is 'n tipe 
breinskandering ("brain scan"), maar behels dat u 'n lae dosering radio-
aktiewe middel ingespuit word om die beeld van die brein te versterk. Die 
hoeveelheid bestraling wat u sal ontvang, is ongeveer gelyk aan die 
dosis betrokke by 'n koronêre angiogram (bloedvatstudie). Indien u 
twee sulke studies sal ondergaan, is die stralingsdosis ongeveer 
dieselfde of ietwat meer as wat ‘n persoon wat met met bestraling werk 
per jaar mag ontvang.  U sal gevra word om vir ten minste 30 minute stil te 
lê vir hierdie toets. Voor die inspuiting sal u ‘n klein hoeveelheid bitter 
vloeistof moet drink om opname van die radio-aktiewe middel in die 
speekselkliere te beperk. 
 
Wat behels die MR studie? 
Hierdie studie behels ook breinbeelding, maar benodig geen inspuiting nie en 
behels ook nie die gebruik van bestraling nie.     
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Vervoerreëlings 
Privaatvervoer na die SPECT studie (Tygerberghospitaal) en MR studie (City 
Park Hospitaal) sal kosteloos verskaf word. 
   
Wat behels die medikasie? 
Die medikasie wat aan u voorgeskryf sal word, is 'n geregistreerde 
medikament wat die simptome wat u ondervind behoort te verbeter. U sal die 
medikasie daagliks gebruik in een tot twee maal per dag doserings. Dit is 'n 
veilige middel, maar kan soms newe-effekte veroorsaak. Die mees algemene 
newe-effekte is bewerigheid, styfheid, sedasie  en rusteloosheid. 
Onwillekeurige bewegings kom minder dikwels voor. 'n Seldsame ernstige 
toestand wat koors en spierstyfheid tot gevolg kan hê, kan gewoonlik met 
vroegtydige onttrekking van die medikasie en ondersteunende behandeling 
doeltreffend behandel word.  Indien u spierstyfheid ondervind, moet u dit aan 
die dokter rapporteer, wat  voorkomende medikasie daarvoor sal oorweeg. 
 
Is daar alternatiewe medikasie beskikbaar? 
Daar is alternatiewe medikasie beskikbaar, maar dit het gewoonlik 
soortgelyke effekte en newe-effekte as die wat met die studie beoog word. 
Is daar enige voordele? 
U simptome mag tydens die verloop van die studie opklaar. U sal geen 
onkoste hê met betrekking tot die ondersoeke of medikasie nie. 
Is die studie eties aanvaarbaar? 
 138
Die studie is goedgekeur deur die Navorsingskomitee van die Universiteit 
van Stellenbosch se Mediese Fakulteit 
Vertroulikheid?    
Die gewone vertroulikheid tussen dokter en pasiënt sal gehandhaaf word, 
maar die bevindings van die studie sal bekend gemaak word  sonder om u 
identiteit te openbaar.       
Kan ek onttrek tydens die studie? 
U besluit om aan die studie deel te neem, beïnvloed nie u verhouding met u 
dokter of hierdie hospitaal nie. Indien u sou wou onttrek, staan dit u vry om 
sonder nagevolge te onttrek, net soos wat dit die dokter vry staan om u van 
die studie te onttrek indien u nie baat vind daarby nie.     
As u besluit om aan die studie deel te neem, moet u u algemene praktisyn 
daarvan in kennis stel.   
 
Indien u iemand benodig tydens die studie, kan u die volgende persoon 
skakel : 
Naam:............................................................................................................... 
 
Telefoonnommer:..............................................................................................
. 
Die ondersoekende dokter sal enige vrae wat u mag hê beantwoord. As u 
besluit om aan die studie deel te neem, moet u hieronder daarvoor teken: 
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Ek, die ondergetekende, ...................................................., het die 
inligtingstuk gelees en het die inligting wat ek benodig van die 
ondersoekende dokter verkry en gee hiermee my vrywillige toestemming om 
aan hierdie studie (alkohol-geïnduseerde psigose) deel te neem.    
 
Pasiënt se Naam:............................................................................................ 
 
Handtekening:................................................................................................. 
 
Ondersoeker se Naam:.................................................................................... 
 
Handtekening: .................................................................................................  
 
Getuie se Naam: ........................................................................................... 
 
Handtekening :................................................................................................ 
 
Datum:............................................................................................................ 
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Appendix D 
 
 ALCOHOL  INDUCED PSYCHOSIS STUDY  
PATIENT INFORMATION AND INFORMED CONSENT 
 
These guidelines has been compiled to enable you to freely decide whether or 
not to participate in this study.  Please read carefully. 
 
What is the aim of the study? 
You are requested to participate voluntarily in a study that will compare  
brain function in 3 different disorders (alcohol induced psychosis, alcohol 
dependence and schizophrenia)  to that of normal control cases.  
If you suffer from alcohol induced psychosis, you will also be requested to 
participate in a 6 week treatment study with appropriate medication for your 
condition. During this period it would be requested from you not to use other 
medication, alcohol or drugs.  
What is expected from me during the study? 
Should you participate in this study, the doctor will measure your blood 
pressure, pulse rate and weight and he will examine you physically. He will 
ask you various questions during the course of a structured psychiatric 
interview. You will also be requested to allow blood (about  5-10ml or 2-4 
teaspoons) and urine sampling for toxicological screening.  
 
It  will also be arranged that you undergo a brain imaging study (SPECT) and 
a magnetic resonance imaging (MRI) study of the brain. 
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Should you have a diagnosis of alcohol-induced psychosis, you will be 
requested to take your medication regularly  and to attend two further 
appointments during the course (after 3 weeks) and after the study (6 weeks). 
At the end of the study, you will complete the same tests (except the MRI 
study).  
  
What does the psychiatric interview involve? 
The investigator will ask various questions according to standard psychiatric 
questionnaires.  It would be similar to the questions that are usually asked by 
a psychiatrist. 
 
What is a SPECT study? 
The SPECT study involves an imaging study of the brain. It is similar to an 
ordinary  brain scan, but involves the injection of a low dosage radio-active  
substance to amplify the picture of the brain. The amount of radiation you 
will receive is equivalent to that received during a coronary angiogram. 
In subjects where two SPECT studies will be performed, the total amount of 
radiation received by each subject will be about the same or slightly more 
than the yearly permissible dose for a radiation worker.  You will be 
asked to lie still for at least 30 minutes for this test.  Before the injection 
you will be requested to drink a small amount of bitter tasting liquid to 
minimise uptake of the radio-active substance in the salivary glands.  
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What does the MR study consist of? 
This is also a brain imaging study but does not require any injection and does 
not involve any radiation.     
 
Transport Arrangements 
Private transport will be arranged to the SPECT study (Tygerberg Hospital) 
and the MRI study (City Park Hospital) at no further costs.  
 
What does the medication consist of? 
The prescribed medication is registered medicine that should improve the 
symptoms that you are experiencing. You will use the medication daily in once 
to twice daily dosages. It is safe medicine but may sometimes produce side- 
effects. The most common adverse effects are tremors, rigidity, restlessness 
and sedation. Involuntary movements occur less frequently. An uncommon  
serious condition that may cause fever and rigidity, can usually be reversed 
by early withdrawal of medication and supportive management.  Should you 
experience muscle stiffness, you should report it to your doctor who would 
consider preventative medication for the treatment thereof. 
Are there alternative treatments available? 
There is alternative medication available, but it has similar side effects to the 
one proposed for this study. 
Would there be any  advantages? 
Your symptoms may improve during the course of the study. You will have 
no costs with regard to investigations or medication.  
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Has the study been ethically approved? 
The study has been approved by the Research committee of the Medical 
Faculty of the University of Stellenbosch. 
Confidentiality?   
The usual confidentiality between practitioner and patient will be adhered to, 
but the results of the study will be made public without it being possible to 
identify you in any possible way.       
May I withdraw from the trial once it has started? 
Your decision to participate in this study, does not influence your relation 
with the doctor or this hospital.  Should you wish to withdraw, you are 
entitled to leave without negative consequences. Likewise the doctor may 
decide that you leave the study, should it be unlikely that you will benefit 
from further participation.     
If you decide to participate in the study, you need to inform your general 
practitioner.    
 
Should you need someone during the course of the study, you may contact 
the following person: 
Name:............................................................................................................... 
 
Telephone Number........................................................................................... 
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The investigating doctor will answer all questions that you may have. Should 
you decide to paricipate in this study, you have to sign below : 
 
I, the undersigned, ...................................................., have read the 
information sheet and obtained the necessary information from the 
investigating doctor and hereby give my freely obtained consent to 
participate in this study (alcohol induced psychosis).    
 
Name of Patient:.............................................................................................. 
 
Signature:......................................................................................................... 
 
Name of Investigator ........................................................................................ 
 
Signature: ........................................................................................................  
 
Name of Witness:.............................................................................................. 
 
Signature:......................................................................................................... 
 
Date:............................................................................................................ 
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Appendix E 
Rating scales and clinical research instruments 
Agitated Behavior Scale (ABS)  
       
Calgary Depression Scale for Schizophrenia (CDSS) 
 
Clinical Global Impression of  Severity of Psychosis (CGI-SP)  
 
Hamilton Depression Rating Scale (Ham-D) 
 
Hamilton Anxiety Rating Scale  (Ham-A) 
 
Mini-Mental State Examination (MMSE) 
 
Positive and Negative Syndrome Scale (PANSS)    
 
Scale of Functioning (SOF) 
 
Scale to assess unawareness of mental disorder (SUMD) 
 
Severity of Alcohol Dependence Questionnairre (SADQ) 
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Appendix F 
 
SUMMARY OF CHANGES IN  REGIONAL CEREBRAL BLOOD FLOW  IN 
PATIENTS WITH ALCOHOL-INDUCED  PSYCHOTIC DISORDER :  
(Table 22) 
 
              
Brain Region  
MNI 
coordinates 
(x,y,z) 
                                     
Regional Cerebral Blood Flow (rCBF) 
Frontal Lobe 
(Left) 
  
Superior Medial (-8,48,28) Negative correlation between change in rCBF 
and change in Negative PANSS post vs pre 
therapy (p<0.001) 
Superior (-16,36,36) Increased rCBF vs volunteers   (p<0.01) 
 (-20,32,32) Decreased rCBF post vs pre therapy (p<0.01)   
Middle (-32,52,12) Negative correlation between change in rCBF 
and change in Negative PANSS post vs pre 
therapy (p<0.001) 
 (-24,48,8) Increased rCBF vs volunteers   (p<0.01) 
Middle (-36,24,52) Decreased rCBF vs alcohol dependent group   
(p<0.01) 
Inferior 
Operculum  
(-52,16,24) Negative correlation between change in rCBF 
and change in Negative PANSS post vs pre 
therapy (p<0.001) 
Inferior Tri (-32,12,28) Decreased rCBF vs schizophrenia group 
(p<0.001) 
 (-44,20,20) Decreased rCBF vs alcohol dependence group 
(p<0.01)  
Inferior Orbital (-40,28,-16) Decreased rCBF post vs pre therapy (p<0.01)  
 (-40,40,-4) Decreased rCBF vs alcohol dependence group 
(p<0.001)
Mid Orbital (-20,52,-20) Decreased rCBF post vs pre therapy (p<0.01)  
Supplementary  
Motor Area 
(-8,0,68) Increased rCBF post vs pre therapy (p<0.001) 
 (-12,12,64) Negative correlation between change in rCBF 
and change in Negative PANSS post vs pre 
therapy (p<0.001)
Rolandic 
Operculum 
(-48,-20,20) Increased rCBF post vs pre therapy (p<0.001)  
Pre central (-24,-24,64) Increased rCBF post vs pre therapy (p<0.01)   
 (-28,-12,68) Negative correlation between change in rCBF 
and change in Negative PANSS post vs pre 
therapy (p<0.001)
Deep to Pre 
central 
(-44,0,24) Increased rCBF vs volunteers   (p<.001) 
Cingulum Mid (0,-12,40) Increased rCBF post vs pre therapy (p<0.01)   
 (-8,-24,36) Negative correlation between change in rCBF 
and change in Negative PANSS post vs pre 
therapy (p<0.001) 
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Appendix F (table 22) continued 
 
               
Brain Region  
MNI 
coordinate
s (x,y,z) 
                                     
Regional Cerebral Blood Flow (rCBF) 
Frontal Lobe 
(Right) 
  
Superior Medial (16,52,8) Increased rCBF vs volunteer group   (p<0.001) 
Superior (16,40,44) Decreased rCBF vs alcohol dependence group 
(p<0.01) 
 (16,20,52) Decreased rCBF at baseline correlating with 
Negative PANSS (p<0.001) 
Supplementary  
Motor Area 
(12,20,48) Decreased rCBF at baseline correlating with 
Total PANSS (p<0.001) 
 (4,-20,60) Negative correlation between change in rCBF 
and change in General PANSS post vs pre 
therapy (p<0.001) 
Superior Orbital (16,32,-20) Decreased rCBF vs alcohol dependence group 
(p<0.01) 
Mid Orbital  (36,52,-12) Decreased rCBF post vs pre therapy (p<0.01) 
Rolandic 
Operculum  
(40,-8,20) Decreased rCBF at baseline correlating with 
Negative PANSS (p<0.001) 
 (52,-12,12) Negative correlation between change in rCBF 
and change in General PANSS post vs pre 
therapy (p<0.001) 
Inferior 
Operculum 
(36,16,32) Negative correlation between change in rCBF 
and change in Negative PANSS post vs pre 
therapy (p<0.001) 
 (36,12,28) Negative correlation between change in rCBF 
and change in Total PANSS post vs pre therapy 
(p<0.001) 
Middle (28,16,48) Negative correlation between change in rCBF 
and change in General PANSS post vs pre 
therapy (p<0.001) 
 (28,44,24) Negative correlation between change in rCBF 
and change in General PANSS post vs pre 
therapy (p<0.001) 
 (28,44,20) Negative correlation between change in rCBF 
and change in Total PANSS post vs pre therapy 
(p<0.001) 
 (32,44,20) Negative correlation between change in rCBF 
and change in Negative PANSS post vs pre 
therapy (p<0.001) 
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Appendix F (table 22) continued 
 
               
Brain Region  
MNI 
coordinates 
(x,y,z) 
                                     
Regional Cerebral Blood Flow (rCBF) 
Temporal  
Lobe (Left) 
  
Superior (-48,-16,4) Negative correlation between change in rCBF 
and change in General PANSS post vs pre 
therapy (p<0.001) 
Middle (-56,-56,4) Decreased rCBF vs alcohol dependent group   
(p<0.01) 
 (-48,-48,0) Increased rCBF vs volunteer group   (p<0.01) 
Inferior (-44,4,-28) Increased rCBF vs volunteer group   (p<0.01) 
 (-48,-20,-24) Negative correlation between change in rCBF 
and change in Negative PANSS post vs pre 
therapy (p<0.001) 
 (-52,-20,-24) Negative correlation between change in rCBF 
and change in General PANSS post vs pre 
therapy (p<0.001) 
 (-52,-20,-24) Negative correlation between change in rCBF 
and change in Total PANSS post vs pre therapy 
(p<0.001) 
Parahippocampus (-12,4,-20) Increased rCBF vs alcohol dependent group 
(p<0.01)  
 
 
               
Brain Region  
MNI 
coordinates 
(x,y,z) 
                                     
Regional Cerebral Blood Flow (rCBF) 
Temporal  
Lobe (Right) 
  
Middle  (48,-56,0) Increased rCBF vs volunteer group (p<0.01) 
 (56,-44,-4) Decreased rCBF vs alcohol dependent group   
(p<0.01) 
 (52,-64,24) Increased rCBF vs schizophrenia group (p<0.01) 
 (36,8,-28) Increased rCBF vs volunteer group (p<0.01) 
Hippocampus (40,-20,-8) Decreased rCBF post vs pre-treatment (p<0.01) 
Near 
hippocampus  
(40,-4,-20) Decreased rCBF post vs pre-treatment (p<0.01) 
Hippocampus (28,-24,-8) Negative correlation between change in rCBF 
and change in General PANSS post vs pre 
therapy (p<0.001) 
 (28,-24,-4) Negative correlation between change in rCBF 
and change in Total PANSS post vs pre therapy 
(p<0.001) 
Inferior (44,-8,-28) Negative correlation between change in rCBF 
and change in General PANSS post vs pre 
therapy (p<0.001) 
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Appendix F (table 22) continued 
               
Brain Region  
MNI 
coordinates 
(x,y,z) 
                                      
Regional Cerebral Blood Flow (rCBF) 
Basal ganglia  
(Left) 
  
Putamen (-20,16,-4) Decreased rCBF vs alcohol dependence group 
(p<0.001) 
Caudate (-12,16,12) Increased rCBF post vs pre treatment (p<0.001)  
Basal ganglia  
(Right) 
  
Caudate (20,24,4) Decreased rCBF vs alcohol dependence group 
(p<0.01) 
Pallidum (16,-4,0) Increased rCBF vs volunteer group (p<0.01) 
 
               
Brain Region  
MNI 
coordinates 
(x,y,z) 
                                     
Regional Cerebral Blood Flow (rCBF) 
Thalamus   
(Left) 
  
Thalamus  (-16,-12,-4) Increased rCBF vs volunteer group (p<0.01) 
Thalamus  (-8,-20,20) Negative correlation between change in rCBF 
and change in General PANSS post vs pre 
therapy (p<0.001) 
Thalamus    
(Right) 
n/a No correlations found 
 
               
Brain Region  
MNI 
coordinates 
(x,y,z) 
                                     
Regional Cerebral Blood Flow (rCBF) 
Parietal Lobe 
(Left) 
  
Inferior (-28.-48.56) Negative correlation between change in rCBF 
and change in Negative PANSS post vs pre 
therapy (p<0.001) 
Supramarginal  (-56,-20,24) Negative correlation between change in rCBF 
and change in Negative PANSS post vs pre 
therapy (p<0.001) 
 (-56,-20,20)  Negative correlation between change in rCBF 
and change in Total PANSS post vs pre therapy 
(p<0.001) 
Parietal Lobe 
(Right) 
  
Supramarginal (44,-40,44) Negative correlation between change in rCBF 
and change in Negative PANSS post vs pre 
therapy (p<0.001) 
 (40,-36,40) Decreased rCBF at baseline correlating with 
General PANSS (p<0.001)   
Precuneus (12,-56,56) Negative correlation between change in rCBF 
and change in General PANSS post vs pre 
therapy (p<0.001) 
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Appendix F (table 22) continued 
 
 
               
Brain Region  
MNI 
coordinates 
(x,y,z) 
                                     
Regional Cerebral Blood Flow (rCBF) 
Occipital Lobe 
(Left) 
  
Middle (-20,-96,12) Negative correlation between change in rCBF 
and change in Negative PANSS post vs pre 
therapy (p<0.001) 
Occipital Lobe 
(Right) 
  
Inferior (fusiform) (20,-40,-12) Decreased rCBF at baseline correlating with 
Negative PANSS (p<0.001)   
 
               
Brain Region  
MNI 
coordinates 
(x,y,z) 
                                     
Regional Cerebral Blood Flow (rCBF) 
Cerebellum 
(Left) 
  
Cerebellum   (-12,-60,-44) Negative correlation between change in rCBF 
and change in Total PANSS post vs pre therapy 
(p<0.001) 
                     (-12,-60,-40) Negative correlation between change in rCBF 
and change in Negative PANSS post vs pre 
therapy (p<0.001) 
                     (-12,-56,-40) Negative correlation between change in rCBF 
and change in General PANSS post vs pre 
therapy (p<0.001) 
Cerebellum 
(Centre) 
  
Vermis (0,-40,-20) Decreased rCBF at baseline correlating with 
General PANSS (p<0.001)   
Cerebellum 
(Right) 
  
Cerebellum  (8,-80,16) Increased rCBF at baseline correlating with 
Positive PANSS (p<0.001) 
 
 
 
 
 
 
 
 
